<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Mol Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Mol Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">Front. Mol. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Molecular Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="epub">1662-5099</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29867348</article-id>
<article-id pub-id-type="pmc">5962780</article-id>
<article-id pub-id-type="doi">10.3389/fnmol.2018.00156</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Critical Issues in <italic>BDNF</italic> Val66Met Genetic Studies of Neuropsychiatric Disorders</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Tsai</surname>
<given-names>Shih-Jen</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/291169/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Psychiatry, Taipei Veterans General Hospital</institution>, <addr-line>Taipei</addr-line>, <country>Taiwan</country></aff>
<aff id="aff2"><sup>2</sup><institution>School of Medicine, National Yang-Ming University</institution>, <addr-line>Taipei</addr-line>, <country>Taiwan</country></aff>
<aff id="aff3"><sup>3</sup><institution>Institute of Brain Science, National Yang-Ming University</institution>, <addr-line>Taipei</addr-line>, <country>Taiwan</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Guilherme Lucas, Universidade de São Paulo, Brazil</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Rachel Anne Hill, Monash University, Australia; Maarten Van Den Buuse, La Trobe University, Australia</p>
</fn>
<corresp id="c001">*Correspondence: Shih-Jen Tsai, <email>tsai610913@gmail.com</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>15</day>
<month>5</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>11</volume>
<elocation-id>156</elocation-id>
<history>
<date date-type="received">
<day>23</day>
<month>2</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>24</day>
<month>4</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2018 Tsai.</copyright-statement>
<copyright-year>2018</copyright-year>
<copyright-holder>Tsai</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Neurotrophins have been implicated in the pathophysiology of many neuropsychiatric diseases. Brain-derived neurotrophic factor (BDNF) is the most abundant and widely distributed neurotrophin in the brain. Its Val66Met polymorphism (refSNP Cluster Report: rs6265) is a common and functional single-nucleotide polymorphism (SNP) affecting the activity-dependent release of BDNF. <italic>BDNF</italic> Val66Met transgenic mice have been generated, which may provide further insight into the functional impact of this polymorphism in the brain. Considering the important role of BDNF in brain function, more than 1,100 genetic studies have investigated this polymorphism in the past 15 years. Although these studies have reported some encouraging positive findings initially, most of the findings cannot be replicated in following studies. These inconsistencies in <italic>BDNF</italic> Val66Met genetic studies may be attributed to many factors such as age, sex, environmental factors, ethnicity, genetic model used for analysis, and gene–gene interaction, which are discussed in this review. We also discuss the results of recent studies that have reported the novel functions of this polymorphism. Because many <italic>BDNF</italic> polymorphisms and non-genetic factors have been implicated in the complex traits of neuropsychiatric diseases, the conventional genetic association-based method is limited to address these complex interactions. Future studies should apply data mining and machine learning techniques to determine the genetic role of <italic>BDNF</italic> in neuropsychiatric diseases.</p>
</abstract>
<kwd-group>
<kwd>brain-derived neurotrophic factor</kwd>
<kwd>Val66Met polymorphism</kwd>
<kwd>transgenic mice</kwd>
<kwd>genetic study</kwd>
<kwd>age</kwd>
<kwd>sex</kwd>
<kwd>environmental factors</kwd>
<kwd>ethnicity</kwd>
</kwd-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="1"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="173"></ref-count>
<page-count count="15"></page-count>
<word-count count="0"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec>
<title>Introduction</title>
<p>Brain-derived neurotrophic factor (BDNF), a major member of the neurotrophin family, is widely expressed in the mammalian brain (<xref ref-type="bibr" rid="B50">Hofer et al., 1990</xref>). The highest level of BDNF is found in the hippocampus and the cerebral cortex, which are regions of the brain that are involved in many neuropsychiatric diseases (<xref ref-type="bibr" rid="B50">Hofer et al., 1990</xref>). BDNF is critical to the growth, survival, and differentiation of the developing nervous system through its binding to a high affinity tyrosine kinase receptor B (TrkB) and/or the p75 neurotrophin receptor. Mutant mice lacking BDNF exhibit developmental brain abnormalities and die soon after birth (<xref ref-type="bibr" rid="B31">Ernfors et al., 1994</xref>). In addition, BDNF can modulate synaptic transmission and activity-dependent plasticity, and it can promote long-term potentiation (LTP) (<xref ref-type="bibr" rid="B159">Xu et al., 2000</xref>; <xref ref-type="bibr" rid="B10">Bramham and Messaoudi, 2005</xref>).</p>
<p>The human <italic>BDNF</italic> gene is located on chromosome 11p13 and has 11 exons and 9 functional promoters that are brain region- and tissue-specific (<xref ref-type="bibr" rid="B110">Pruunsild et al., 2007</xref>). In this gene, a non-synonymous polymorphism (refSNP Cluster Report: rs6265; also called Val66Met or G196A polymorphism) is common; this polymorphism causes a valine (Val) to methionine (Met) change at position 66 of the proBDNF protein. The replacement of Val by Met impairs the neuronal activity-dependent secretion of BDNF (<xref ref-type="bibr" rid="B29">Egan et al., 2003</xref>). The first two genetic studies investigating the <italic>BDNF</italic> Val66Met polymorphism were published in 2002 (<xref ref-type="bibr" rid="B94">Momose et al., 2002</xref>; <xref ref-type="bibr" rid="B150">Ventriglia et al., 2002</xref>). Considering the important role of BDNF in the brain, over the past 15 years, many genetic studies have investigated the effects of this <italic>BDNF</italic> polymorphism on brain function and behavior in health, as well as in diseases, particularly neuropsychiatric diseases (<xref ref-type="bibr" rid="B52">Hong et al., 2011</xref>; <xref ref-type="bibr" rid="B101">Notaras et al., 2015b</xref>) (<bold>Table <xref ref-type="table" rid="T1">1</xref></bold>). A search with the keywords “(bdnf val66met) OR rs6265 OR (bdnf g196a) OR (bdnf 196g/a) OR (bdnf 196a/g) OR (bdnf 196 a/g)” performed in the PubMed database up to February 14, 2018 found 1,176 reports on this polymorphism (<bold>Figure <xref ref-type="fig" rid="F1">1</xref></bold>). Although many reports have demonstrated the possible genetic effects of this <italic>BDNF</italic> polymorphism in diseases or brain function, other reports have failed to replicate the findings. The inconsistent findings of <italic>BDNF</italic> Val66Met genetic studies may result from many factors such as age, sex, environmental factors, ethnicity, genetic model used for analysis, and gene–gene interaction. In this review, we discuss these issues in genetic studies of the <italic>BDNF</italic> Val66Met polymorphism. We also discuss some findings for the novel function of this polymorphism.</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>Meta-analyses of studies of the <italic>BDNF</italic> Val66Met polymorphism in neuropsychiatric diseases.</p>
</caption>
<table cellpadding="5" cellspacing="5" frame="hsides" rules="groups">
<thead>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<th align="left" colspan="1" rowspan="1" valign="top">Number of</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">Disease/phenotype</th>
<th align="left" colspan="1" rowspan="1" valign="top">Studies</th>
<th align="left" colspan="1" rowspan="1" valign="top">studies</th>
<th align="left" colspan="1" rowspan="1" valign="top">Participants</th>
<th align="left" colspan="1" rowspan="1" valign="top">Result</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Major depressive disorder</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B151">Verhagen et al., 2010</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">14</td>
<td align="left" colspan="1" rowspan="1" valign="top">2,812 cases; 10,843 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Met increased risk for depression in men but not in women.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B105">Pei et al., 2012</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">5</td>
<td align="left" colspan="1" rowspan="1" valign="top">523 cases; 1,220 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Met increased risk for geriatric depression.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B42">Gyekis et al., 2013</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">26</td>
<td align="left" colspan="1" rowspan="1" valign="top">4,582 cases; 12,995 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lack of association.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B54">Hosang et al., 2014</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">22</td>
<td align="left" colspan="1" rowspan="1" valign="top">14,233 participants</td>
<td align="left" colspan="1" rowspan="1" valign="top">Val66Met polymorphism significantly moderated the relationship between life stress and depression.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B168">Zhao M. et al., 2017</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">31</td>
<td align="left" colspan="1" rowspan="1" valign="top">21,060 participants</td>
<td align="left" colspan="1" rowspan="1" valign="top">Life stress interacted with the Met in depression risk.</td>
</tr>
<tr>
<td align="left" colspan="5" rowspan="1" valign="top">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Response to antidepressant</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B173">Zou et al., 2010</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">8</td>
<td align="left" colspan="1" rowspan="1" valign="top">1,115 cases</td>
<td align="left" colspan="1" rowspan="1" valign="top">Val66Met heterozygous patients had a better response rate in comparison to Val homozygous patients, especially in Asian population.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B162">Yan et al., 2014</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">16</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Met carriers had a better response rate than Val/Val carriers in Asians.</td>
</tr>
<tr>
<td align="left" colspan="5" rowspan="1" valign="top">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Suicide behaviors</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B166">Zai et al., 2012</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">12</td>
<td align="left" colspan="1" rowspan="1" valign="top">1,202 cases; 2,150 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Met carriers and Met allele conferred risk for suicide.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B39">Gonzalez-Castro et al., 2017</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">23</td>
<td align="left" colspan="1" rowspan="1" valign="top">4,532 cases; 5,364 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Met is the risk allele in Caucasian; Val is the risk allele in Asian.</td>
</tr>
<tr>
<td align="left" colspan="5" rowspan="1" valign="top">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Bipolar disorder</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B65">Kanazawa et al., 2007</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">11</td>
<td align="left" colspan="1" rowspan="1" valign="top">3,143 cases; 6,347 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lack of association.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B38">Gonzalez-Castro et al., 2015</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">22</td>
<td align="left" colspan="1" rowspan="1" valign="top">9,349 cases; 7,437 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lack of association.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B154">Wang et al., 2014</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">21</td>
<td align="left" colspan="1" rowspan="1" valign="top">7,219 cases; 9,832 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lack of association.</td>
</tr>
<tr>
<td align="left" colspan="5" rowspan="1" valign="top">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Schizophrenia</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B171">Zintzaras, 2007</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">9</td>
<td align="left" colspan="1" rowspan="1" valign="top">1,404 cases; 1597 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lack of association.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B161">Xu et al., 2007</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">11</td>
<td align="left" colspan="1" rowspan="1" valign="top">3,032 cases; 4,080 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lack of association.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B97">Naoe et al., 2007</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">8</td>
<td align="left" colspan="1" rowspan="1" valign="top">2,059 cases; 2,765 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lack of association.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B41">Gratacos et al., 2007</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">12</td>
<td align="left" colspan="1" rowspan="1" valign="top">3,338 cases; 4,635 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Met/Met increased the risk of schizophrenia.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B111">Qian et al., 2007</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">16</td>
<td align="left" colspan="1" rowspan="1" valign="top">2,991 cases; 3,962 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lack of association.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B65">Kanazawa et al., 2007</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">13</td>
<td align="left" colspan="1" rowspan="1" valign="top">2,955 cases; 4,035 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lack of association.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B67">Kawashima et al., 2009</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">22</td>
<td align="left" colspan="1" rowspan="1" valign="top">6,568 cases; 8,824 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lack of association.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B69">Kheirollahi et al., 2016</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">39</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Met/Met increased the risk of schizophrenia in Asian and European populations.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B170">Zhao et al., 2015</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">44</td>
<td align="left" colspan="1" rowspan="1" valign="top">11,480 cases; 13,490 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lack of association.</td>
</tr>
<tr>
<td align="left" colspan="5" rowspan="1" valign="top">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Response to antipsychotics</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B15">Cargnin et al., 2016</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">9</td>
<td align="left" colspan="1" rowspan="1" valign="top">2,461 antipsychotic-treated patients</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lack of association.</td>
</tr>
<tr>
<td align="left" colspan="5" rowspan="1" valign="top">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Antipsychotic-induced tardive dyskinesia</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B92">Miura et al., 2014</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">6</td>
<td align="left" colspan="1" rowspan="1" valign="top">1,740 antipsychotic-treated patients</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lack of association.</td>
</tr>
<tr>
<td align="left" colspan="5" rowspan="1" valign="top">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Generalized Anxiety Disorder</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B34">Frustaci et al., 2008</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">7</td>
<td align="left" colspan="1" rowspan="1" valign="top">1,092 cases; 8,394 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lack of association.</td>
</tr>
<tr>
<td align="left" colspan="5" rowspan="1" valign="top">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Neuroticism</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B34">Frustaci et al., 2008</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">5</td>
<td align="left" colspan="1" rowspan="1" valign="top">1,633 participants</td>
<td align="left" colspan="1" rowspan="1" valign="top">Met carriers had lower Neuroticism score.</td>
</tr>
<tr>
<td align="left" colspan="5" rowspan="1" valign="top">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Posttraumatic stress disorder (PTSD)</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B153">Wang, 2015</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">6</td>
<td align="left" colspan="1" rowspan="1" valign="top">696 cases; 1,726 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lack of association.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B12">Bruenig et al., 2016</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">9</td>
<td align="left" colspan="1" rowspan="1" valign="top">1,066 cases; 2,559 were controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Met carriers had increased risk of PTSD.</td>
</tr>
<tr>
<td align="left" colspan="5" rowspan="1" valign="top">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Panic disorder</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B19">Chen et al., 2017</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">6</td>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">A significant association in recessive model.</td>
</tr>
<tr>
<td align="left" colspan="5" rowspan="1" valign="top">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Obsessive-compulsive disorder</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B152">Wang et al., 2015</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">8</td>
<td align="left" colspan="1" rowspan="1" valign="top">1,632 cases; 2,417 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lack of association.</td>
</tr>
<tr>
<td align="left" colspan="5" rowspan="1" valign="top">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Attention-deficit hyperactivity disorder</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B115">Sanchez-Mora et al., 2010</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">4</td>
<td align="left" colspan="1" rowspan="1" valign="top">1,445 adulthood patients; 2,247;controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lack of association.</td>
</tr>
<tr>
<td align="left" colspan="5" rowspan="1" valign="top">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Eating disorder</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B41">Gratacos et al., 2007</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">5</td>
<td align="left" colspan="1" rowspan="1" valign="top">1,733cases; 1,811 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Met increased the risk of eating disorder.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B11">Brandys et al., 2013</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">9</td>
<td align="left" colspan="1" rowspan="1" valign="top">2,767 cases; 3,322 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lack of association.</td>
</tr>
<tr>
<td align="left" colspan="5" rowspan="1" valign="top">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Cognition</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B64">Kambeitz et al., 2012</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">32</td>
<td align="left" colspan="1" rowspan="1" valign="top">5,922 participants</td>
<td align="left" colspan="1" rowspan="1" valign="top">Met carriers performed worse than the Val homozygotes in memory.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B88">Mandelman and Grigorenko, 2012</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">23</td>
<td align="left" colspan="1" rowspan="1" valign="top">7,095 participants</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lack of association.</td>
</tr>
<tr>
<td align="left" colspan="5" rowspan="1" valign="top">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Hippocampal volume</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B44">Hajek et al., 2012</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">7</td>
<td align="left" colspan="1" rowspan="1" valign="top">399 participants</td>
<td align="left" colspan="1" rowspan="1" valign="top">Met carriers had smaller hippocampal volumes than Val homozygotes.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B46">Harrisberger et al., 2014</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">27</td>
<td align="left" colspan="1" rowspan="1" valign="top">5,298 participants</td>
<td align="left" colspan="1" rowspan="1" valign="top">Met carriers had slightly smaller hippocampal volumes than Val homozygotes.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B45">Harrisberger et al., 2015</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">18</td>
<td align="left" colspan="1" rowspan="1" valign="top">1,695 neuropsychiatric patients</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lack of association.</td>
</tr>
<tr>
<td align="left" colspan="5" rowspan="1" valign="top">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Alcohol dependence</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B33">Forero et al., 2015</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">9</td>
<td align="left" colspan="1" rowspan="1" valign="top">2,553 cases; 2,709 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lack of association.</td>
</tr>
<tr>
<td align="left" colspan="5" rowspan="1" valign="top">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Substance abuse</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B41">Gratacos et al., 2007</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">6</td>
<td align="left" colspan="1" rowspan="1" valign="top">1,361 cases; 1,164 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Val homozygotes conferred risk for substance abuse.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B43">Haerian, 2013</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">20</td>
<td align="left" colspan="1" rowspan="1" valign="top">4,665 cases; 4,754 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Val increased the risk of methamphetamine dependence in south Asian participants and the risk of heroin dependence in Chinese participants.</td>
</tr>
<tr>
<td align="left" colspan="5" rowspan="1" valign="top">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Adult-onset dystonia</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B37">Gomez-Garre et al., 2014</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">7</td>
<td align="left" colspan="1" rowspan="1" valign="top">1,936 cases; 2,519 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lack of association.</td>
</tr>
<tr>
<td align="left" colspan="5" rowspan="1" valign="top">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Migraine</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B125">Terrazzino et al., 2017</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">5</td>
<td align="left" colspan="1" rowspan="1" valign="top">1,442 cases; 1,880 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Met increased the risk of migraine.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B13">Cai et al., 2017</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">4</td>
<td align="left" colspan="1" rowspan="1" valign="top">1,598 cases; 1,585 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Met increased the risk of migraine.</td>
</tr>
<tr>
<td align="left" colspan="5" rowspan="1" valign="top">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Parkinson’s disease</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B172">Zintzaras and Hadjigeorgiou, 2005</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">6</td>
<td align="left" colspan="1" rowspan="1" valign="top">1,419 cases; 1,406 controls.</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lack of association.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B24">Dai et al., 2013</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">13</td>
<td align="left" colspan="1" rowspan="1" valign="top">3,333 cases; 3,418 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lack of association.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B89">Mariani et al., 2015</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">15</td>
<td align="left" colspan="1" rowspan="1" valign="top">3,754 cases; 4,026 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lack of association.</td>
</tr>
<tr>
<td align="left" colspan="5" rowspan="1" valign="top">
<hr/>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Alzheimer’s disease (AD)</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B35">Fukumoto et al., 2010</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">16</td>
<td align="left" colspan="1" rowspan="1" valign="top">4,711 cases; 4,537 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Met increased the risk of AD in women, but not in men.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B82">Lin et al., 2014</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">29</td>
<td align="left" colspan="1" rowspan="1" valign="top">7,548 cases; 7,334 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Met increased the risk of AD in Caucasian females.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<xref ref-type="bibr" rid="B58">Ji et al., 2015</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">23</td>
<td align="left" colspan="1" rowspan="1" valign="top">6,504 cases; 6,636 controls</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lack of association.</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>A search for reports on the <italic>BDNF</italic> Val66Met polymorphism with the keywords “(bdnf val66met) OR rs6265 OR (bdnf g196a) OR (bdnf 196g/a) OR (bdnf 196a/g) OR (bdnf 196 a/g)” performed in the PubMed database up to February 14, 2018.</p>
</caption>
<graphic xlink:href="fnmol-11-00156-g001"></graphic>
</fig>
</sec>
<sec>
<title><italic>BDNF</italic> Val66Met Polymorphism and Ethnicity</title>
<p>Meta-analysis, which is a statistical tool for combining the results of different studies investigating the same topic, can provide convincing and reliable evidence relevant to genetic studies with differing results. Several meta-analyses of <italic>BDNF</italic> Val66Met polymorphism studies have demonstrated that the positive association findings of this polymorphism are dependent on ethnicity (<bold>Table <xref ref-type="table" rid="T1">1</xref></bold>). For example, converging evidence suggests that BDNF is implicated in the pathogenesis of bipolar disorder. In 2003, two research groups reported a significant association between the <italic>BDNF</italic> Val66Met polymorphism and bipolar disorder (<xref ref-type="bibr" rid="B98">Neves-Pereira et al., 2002</xref>; <xref ref-type="bibr" rid="B119">Sklar et al., 2002</xref>). However, most of the other studies cannot replicate this association (<xref ref-type="bibr" rid="B51">Hong et al., 2003a</xref>; <xref ref-type="bibr" rid="B96">Nakata et al., 2003</xref>). In 2016, due to the lack of reproducibility, <xref ref-type="bibr" rid="B76">Li et al. (2016)</xref> performed a systematic meta-analysis of reports evaluating diverse ethnic groups. They found that the <italic>BDNF</italic> Val66Met polymorphism is significantly associated with bipolar disorder in Europeans, but not in Asians.</p>
<p>Brain-derived neurotrophic factor is characterized by survival-promoting activity in various brain neurons, including midbrain dopaminergic variants. Postmortem brain studies have suggested that BDNF is involved in the pathogenesis of Parkinson’s disease (PD) (<xref ref-type="bibr" rid="B62">Joyce et al., 2002</xref>; <xref ref-type="bibr" rid="B53">Hong et al., 2003b</xref>). Therefore, genetic studies have tested the association of this polymorphism with PD risk but have reported inconsistent results. A meta-analysis of 12 studies showed no association between PD and this <italic>BDNF</italic> polymorphism in all study subjects (<xref ref-type="bibr" rid="B75">Lee and Song, 2014</xref>). However, an ethnicity-specific meta-analysis showed that Met carriers have an increased susceptibility to PD in Europeans, but not in Asians.</p>
<p>Strong evidence suggests genetic predisposition to suicidal behaviors (<xref ref-type="bibr" rid="B142">Tsai et al., 2011</xref>). To determine the genetic effect of the <italic>BDNF</italic> Val66Met polymorphism on suicidal behaviors, a meta-analysis evaluated 23 studies, including 4,532 patients and 5,364 controls, but found no evidence of an association between this polymorphism and suicidal behaviors (<xref ref-type="bibr" rid="B39">Gonzalez-Castro et al., 2017</xref>). However, a significantly increased risk was found in a subgroup analysis by ethnicity in Asian populations (Val homozygotes vs. Met carriers: odds ratio [OR]: 1.36; 95% confidence interval [CI], 1.04–1.78) and in Caucasian populations (Met homozygotes vs. Val carriers: OR: 1.96; 95% CI, 1.58–2.43).</p>
<p>The disparate associations among ethnic groups may be attributed to several reasons. First, considerable <italic>BDNF</italic> allele and haplotype diversity is present among populations globally, and the frequency of the Met allele considerably ranges from 0 to 72% across populations (<xref ref-type="bibr" rid="B106">Petryshen et al., 2010</xref>). The low prevalence of the risk allele in some populations may lead to an inadequate population size in studies validating associations found to be significant in low-powered studies. Second, the Met allele is present in different population-specific haplotypes in Caucasians and Asians (<xref ref-type="bibr" rid="B106">Petryshen et al., 2010</xref>). If the <italic>BDNF</italic> Val66Met polymorphism is not the true risk variant but links to the probable true functional loci with differing strengths among populations, different associations with the Val66Met polymorphism may be found due to different haplotypic backgrounds. Third, different interactions may occur between the <italic>BDNF</italic> Val66Met polymorphism with other genetic or environmental features that vary among ethnic groups.</p>
</sec>
<sec>
<title>Genetic Model for Analysis of <italic>BDNF</italic> Val66Met Polymorphism</title>
<p>The genetic model for the analysis of an single-nucleotide polymorphism (SNP), such as the <italic>BDNF</italic> Val66Met polymorphism, may be dominant (Met carriers vs. Val/Val), codominant (Met/Met vs. Val/Met vs. Val/Val), or recessive (Met/Met vs. Val carriers). The <italic>BDNF</italic> Met allelic frequency is often reported to be high in Asian populations but low in Caucasian, Central and South American, and African populations (<xref ref-type="bibr" rid="B141">Tsai et al., 2010</xref>; <xref ref-type="bibr" rid="B52">Hong et al., 2011</xref>; <xref ref-type="bibr" rid="B39">Gonzalez-Castro et al., 2017</xref>). Many studies in non-Asian populations have grouped carriers of <italic>BDNF</italic> Val/Met and Met/Met genotypes together as Met carriers because of the small number of Met homozygotes. However, whether the Met allele is dominant, codominant, or recessive is unclear. Furthermore, stratifying the <italic>BDNF</italic> Val66Met polymorphism into two genotypic groups may ignore the molecular heterosis effect. For example, a meta-analysis suggested that Val/Met heterozygotes show higher antidepressant therapeutic effects than Val or Met homozygotes, particularly Asian patients (<xref ref-type="bibr" rid="B151">Verhagen et al., 2010</xref>; <xref ref-type="bibr" rid="B173">Zou et al., 2010</xref>; <xref ref-type="bibr" rid="B162">Yan et al., 2014</xref>). This is referred to as the positive molecular heterosis effect, in which subjects heterozygous for a specific genetic polymorphism show a greater effect (<xref ref-type="bibr" rid="B138">Tsai et al., 2003</xref>; <xref ref-type="bibr" rid="B83">Liu et al., 2014</xref>). This observation is consistent with the findings an animal study showing that although BDNF exerts an antidepressant effect, very high BDNF expression may have an unfavorable effect on mood (<xref ref-type="bibr" rid="B40">Govindarajan et al., 2006</xref>).</p>
<p>The association between the <italic>BDNF</italic> Val66Met polymorphism and panic disorder is inconclusive given the mixed findings (<xref ref-type="bibr" rid="B74">Lam et al., 2004</xref>; <xref ref-type="bibr" rid="B20">Chen and Tsai, 2016</xref>). A meta-analysis of six studies found no association between the polymorphism and panic disorder in the dominant model (<xref ref-type="bibr" rid="B19">Chen et al., 2017</xref>). However, in the recessive model, a significant association was found between the <italic>BDNF</italic> Val66Met polymorphism and panic disorder.</p>
</sec>
<sec>
<title><italic>BDNF</italic> Val66Met Polymorphism and Sex</title>
<p>There are sex differences in brain BDNF and its receptor expression. Animal study illustrated that male mice have higher BDNF in the frontal cortex, hippocampus and brain stem (<xref ref-type="bibr" rid="B122">Szapacs et al., 2004</xref>). The distribution of phosphorylated TrkB receptor in the mouse hippocampal formation depends on sex and estrous cycle stages that phosphorylated TrkB were more abundant in high-estradiol states (proestrus females) than low-estradiol states (estrus and diestrus females and males) (<xref ref-type="bibr" rid="B121">Spencer-Segal et al., 2011</xref>). In human, postmortem study found that there is no significant difference in hippocampal BDNF levels between the two genders but female subjects have higher BDNF in the prefrontal cortex (<xref ref-type="bibr" rid="B48">Hayley et al., 2015</xref>). Sex differences in the level of BDNF and its receptor in different brain regions could potentially explain some of the disorder-specific sex differences in the association of <italic>BDNF</italic> Val66Met polymorphism.</p>
<p>In the brain, sex hormones and BDNF have mutual effects. The first linkage between BDNF and sex steroids was indicated in a study showing co-localization of BDNF and its receptor in the estrogen receptor (ER) mRNA-containing neurons during forebrain development (<xref ref-type="bibr" rid="B126">Toran-Allerand et al., 1992</xref>). Evidence from animal studies suggested that estrogen modulates <italic>BDNF</italic> expressions through at least four different mechanisms (<xref ref-type="bibr" rid="B36">Gibbs, 1998</xref>; <xref ref-type="bibr" rid="B17">Chan and Ye, 2017</xref>). First of all, estrogen can directly induce <italic>BDNF</italic> expression by activating ER. Second, estrogen modifies the activity of <italic>BDNF</italic> promoter epigenetically. Third, the ER regulates the activity of CREB, a major transcription factor that controls <italic>BDNF</italic> expression in neurons, through non-genomic activities. Lastly, estrogen affects <italic>BDNF</italic> expression indirectly via inter-neuronal activity. In contrast, evidence suggests that some estrogen actions are mediated by BDNF. For example, BDNF was reported to modulate estradiol-induced dendritic spine formation in rat hippocampal neurons (<xref ref-type="bibr" rid="B95">Murphy et al., 1998</xref>).</p>
<p>Within the hippocampus, estrogen and BDNF both interact with a number of common receptors, enzymes and proteins such as MAP kinase, ERKs, PI3 kinase, CaMKII, CREB, and Src/Fyn (<xref ref-type="bibr" rid="B87">Luine and Frankfurt, 2013</xref>). The interactions between BDNF and estrogen affect hippocampal neurons during development and in adulthood, and these interactions play an important role in the normal brain as well as in diseases (<xref ref-type="bibr" rid="B47">Harte-Hargrove et al., 2013</xref>).</p>
<p>When compared with estrogen, the effect of androgen on <italic>BDNF</italic> expression is less studied. Study in mice demonstrated that gonadectomy induced a significant decrease in the BDNF levels in the hippocampal CA1 area, which were prevented by replacement of testosterone, the major component of androgens (<xref ref-type="bibr" rid="B77">Li et al., 2012</xref>). Androgens are crucial for the development of male-specific behaviors and for physiological functioning. Animal studies have demonstrated that BDNF and androgens may work cooperatively to influence neuronal plasticity and modulate hippocampal function (<xref ref-type="bibr" rid="B102">Ottem et al., 2013</xref>; <xref ref-type="bibr" rid="B4">Atwi et al., 2016</xref>).</p>
<p>An animal study demonstrated the effect of sex hormones on BDNF; female <italic>BDNF</italic><sup>Met/Met</sup> transgenic mice exhibited significant fluctuations in anxiety-like behaviors over the estrous cycle; specifically, these mice exhibited increased anxiety-like behaviors during the estrus phase (<xref ref-type="bibr" rid="B6">Bath et al., 2012a</xref>). A human study found that during the menstrual cycle, plasma BDNF levels were significantly higher in the luteal phase than in the follicular phase (<xref ref-type="bibr" rid="B8">Begliuomini et al., 2007</xref>). A recent multimodal imaging study in 39 healthy women found an ovarian hormone-by-<italic>BDNF</italic> interaction on working memory-related hippocampal function, suggesting that differential hippocampal recruitment occurs in Met carriers but only in the presence of estradiol (<xref ref-type="bibr" rid="B156">Wei et al., 2017</xref>).</p>
<p>Studies from the fields of genetic epidemiology, clinical psychiatry, behavioral neuroscience and neuroimaging suggest that the <italic>BDNF</italic> Val66Met polymorphism may not be a major risk allele for the development of schizophrenia <italic>per se</italic>, but the polymorphism modulates a range of clinical features of the illness, including age of onset, symptoms, therapeutic responsiveness, neurocognitive function and brain morphology (<xref ref-type="bibr" rid="B100">Notaras et al., 2015a</xref>). Findings from clinical and animal studies of schizophrenia showed that estrogen may provide a protective effect in schizophrenia, including through mediating <italic>BDNF</italic> expression and activity (<xref ref-type="bibr" rid="B157">Wu et al., 2013</xref>). This posited estrogen-BDNF interaction could play a key role in sex differences in clinical aspects of schizophrenia.</p>
<p>Because sex hormones may affect BDNF function, sex may contribute to the discrepancy in the findings of <italic>BDNF</italic> Val66Met genetic studies. For example, BDNF plays a critical role in neuronal survival, synaptic plasticity, and memory (<xref ref-type="bibr" rid="B128">Tsai, 2003b</xref>; <xref ref-type="bibr" rid="B55">Huang et al., 2014</xref>; <xref ref-type="bibr" rid="B81">Lin et al., 2016</xref>). Therefore, <italic>BDNF</italic> is a favorable candidate for Alzheimer’s disease (AD) genetic studies. The first genetic association study of the <italic>BDNF</italic> Val66Met polymorphism and AD demonstrated that Val is the risk allele for AD (<xref ref-type="bibr" rid="B150">Ventriglia et al., 2002</xref>). Studies attempting to replicate this finding have obtained inconsistent results (<xref ref-type="bibr" rid="B143">Tsai et al., 2004a</xref>, <xref ref-type="bibr" rid="B144">2006</xref>). To establish the true effect of the <italic>BDNF</italic> polymorphism on AD, <xref ref-type="bibr" rid="B35">Fukumoto et al. (2010)</xref> performed a meta-analysis of studies investigating the effects of the <italic>BDNF</italic> Val66Met polymorphism on AD. The results revealed a clear sex difference in the allelic association; the Met allele confers susceptibility to AD in women (<italic>P</italic> = 0.002), but not in men. This finding suggests that the <italic>BDNF</italic> Val66Met polymorphism has a sexually dimorphic effect on susceptibility to AD. This result is consistent with the finding that the <italic>BDNF</italic> Val66Met polymorphism has a sex-specific role (in women, but not in men) in cognitive function during normal cognitive aging (<xref ref-type="bibr" rid="B73">Laing et al., 2012</xref>). Similarly, a meta-analysis of studies evaluating the effect of the <italic>BDNF</italic> Val66Met polymorphism on major depressive disorder showed that, in the total sample, the <italic>BDNF</italic> Val66Met polymorphism is not significantly associated with depression; however, sex-stratified allelic and genotypic analyses revealed significant effects in men (<xref ref-type="bibr" rid="B151">Verhagen et al., 2010</xref>).</p>
<p>Sex-specific associations of the <italic>BDNF</italic> Val66Met polymorphism with cortisol responses to mental stress (<xref ref-type="bibr" rid="B60">Jiang et al., 2017</xref>), neurocognitive function in schizophrenia (<xref ref-type="bibr" rid="B70">Kim et al., 2016</xref>), sympathetic tone (<xref ref-type="bibr" rid="B18">Chang et al., 2014</xref>), HPA axis reactivity to psychological stress (<xref ref-type="bibr" rid="B116">Shalev et al., 2009</xref>), and attention-deficit/hyperactivity disorder (ADHD) (<xref ref-type="bibr" rid="B23">Cho et al., 2010</xref>) have also been reported.</p>
<p>In addition to <italic>BDNF</italic> Val66Met genetic studies in neuropsychiatric diseases, studies of serum BDNF levels in neuropsychiatric diseases have shown a sex effect. For example, BDNF has been implicated in the pathogenesis of ADHD (<xref ref-type="bibr" rid="B127">Tsai, 2003a</xref>, <xref ref-type="bibr" rid="B136">2017a</xref>; <xref ref-type="bibr" rid="B146">Tzang et al., 2013</xref>). In a recent meta-analysis of studies examining peripheral BDNF levels in ADHD, although no significant difference was found in peripheral BDNF levels between ADHD patients and normal controls, overall, BDNF levels were significantly higher in male ADHD subjects than in male controls (<xref ref-type="bibr" rid="B167">Zhang et al., 2017</xref>).</p>
</sec>
<sec>
<title><italic>BDNF</italic> Val66Met Polymorphism and Age</title>
<p>The tissue expression of BDNF varies across the life span. The human serum BDNF concentration increases in the first several years of life and then slightly decreases in adulthood (<xref ref-type="bibr" rid="B66">Katoh-Semba et al., 2007</xref>). Another study found that plasma BDNF levels decrease significantly with age, whereas platelet levels do not, suggesting the age effect on BDNF levels is tissue-specific (<xref ref-type="bibr" rid="B85">Lommatzsch et al., 2005</xref>). Age not only affects BDNF expression but also affects the conversion of proBDNF to mature BDNF. A study examining BDNF expression in mouse hippocampal lysates showed that the expression of both pro- and mature BDNF was low on postnatal day 0 (<xref ref-type="bibr" rid="B163">Yang et al., 2014</xref>). The expression of proBDNF peaked on postnatal day 15 and declined in later stages. The expression of mature BDNF peaked on postnatal day 21 and plateaued in adulthood (<xref ref-type="bibr" rid="B163">Yang et al., 2014</xref>).</p>
<p>Brain-derived neurotrophic factor is involved in pruning and shaping the adolescent brain and has been implicated in the pathogenesis of neurodevelopmental disorders. Study in male mice found significant changes in BDNF expressions in the forebrain regions during weeks 7–10 (<xref ref-type="bibr" rid="B49">Hill et al., 2012</xref>). Castration and testosterone replacement experiments demonstrated an androgen receptor-dependent effect on BDNF-TrkB signaling in the forebrain and hippocampal regions during adolescence. Female mice showed changes in BDNF-TrkB signaling at a much earlier time point (weeks 4–8) in the forebrain and hippocampal regions (<xref ref-type="bibr" rid="B49">Hill et al., 2012</xref>). During adolescence, the incidence of mental illnesses such as schizophrenia and depression increases substantially. Accordingly, altered synthesis and/or activity of BDNF, which are key regulators of many mental disorders, may contribute to the development of these mental diseases in adolescence.</p>
<p>Studies examining the (mRNA and protein) expression of BDNF and its receptors in the hippocampus and hypothalamus throughout the life span of rats have found that receptors, rather than BDNF itself, are impaired with aging (<xref ref-type="bibr" rid="B117">Silhol et al., 2005</xref>; <xref ref-type="bibr" rid="B112">Rage et al., 2007</xref>). These findings suggest that age also affects BDNF signaling through changes in its receptor.</p>
<p>Based on the aforementioned findings, age may mediate the effect of the <italic>BDNF</italic> Val66Met polymorphism on disease susceptibility. In our studies of the <italic>BDNF</italic> Val66Met polymorphism and major depression, we found that Met carriers have an increased risk of geriatric depression, but not non-geriatric depression (<xref ref-type="bibr" rid="B51">Hong et al., 2003a</xref>; <xref ref-type="bibr" rid="B138">Tsai et al., 2003</xref>; <xref ref-type="bibr" rid="B56">Hwang et al., 2006</xref>). This finding was further confirmed by a meta-analysis of five studies including 523 patients with geriatric depression and 1,220 psychiatrically healthy controls (<xref ref-type="bibr" rid="B105">Pei et al., 2012</xref>). Similarly, a recent study showed a complex relationship between the <italic>BDNF</italic> Val66Met polymorphism and mortality for traumatic brain injury, and that study demonstrated that this polymorphism interacts with age to influence survival predictions beyond clinical variables alone (<xref ref-type="bibr" rid="B32">Failla et al., 2015</xref>).</p>
</sec>
<sec>
<title><italic>BDNF</italic> Val66Met Polymorphism and Gene–Gene Interaction</title>
<p>Brain-derived neurotrophic factor exerts its trophic action mainly by signaling through the trkB receptor (encoded by the <italic>NTRK2</italic> gene). The trkB signaling pathway involves many proteins that also possibly affect BDNF function. In addition, the proteolytic cleavage of proBDNF (a BDNF precursor with effects opposite to those of BDNF) to BDNF by plasmin determines the direction of BDNF action (<xref ref-type="bibr" rid="B86">Lu et al., 2005</xref>; <xref ref-type="bibr" rid="B137">Tsai, 2017b</xref>). Therefore, polymorphisms in the genes encoding proteins involved in the trkB or plasmin signaling pathway may interact with the <italic>BDNF</italic> Val66Met polymorphism to affect disease susceptibility (<xref ref-type="bibr" rid="B129">Tsai, 2004a</xref>, <xref ref-type="bibr" rid="B134">2007b</xref>; <xref ref-type="bibr" rid="B56">Hwang et al., 2006</xref>). For example, using a generalized multifactor dimensionality reduction method, we found the <italic>BDNF</italic> Val66Met polymorphism interacts with <italic>NTRK2</italic> genetic polymorphisms (rs1187323 and rs1778929) to affect susceptibility to geriatric depression (<xref ref-type="bibr" rid="B79">Lin et al., 2009</xref>).</p>
<p>The <italic>BDNF</italic> Val66Met polymorphism has also been reported to interact with the 𝜀4 allele of <italic>apolipoprotein E</italic> (<italic>APOE</italic>), thereby affecting AD susceptibility in women (<xref ref-type="bibr" rid="B169">Zhao Q. et al., 2017</xref>). Another study found that the <italic>BDNF</italic> Val66Met polymorphism interacts with the serotonin transporter gene polymorphism to influence neuroticism-related personality traits (<xref ref-type="bibr" rid="B124">Terracciano et al., 2010</xref>). Recently, <xref ref-type="bibr" rid="B108">Prats et al. (2017)</xref> demonstrated an interaction between the rs1475157 polymorphism of <italic>NRN1</italic> (a neurotrophic factor involved in synaptic plasticity) and the <italic>BDNF</italic> Val66Met polymorphism; this interaction modulated depressive symptoms in 410 non-clinical participants (<xref ref-type="bibr" rid="B108">Prats et al., 2017</xref>).</p>
<p>To analyze interactions in genetic data, many statistical methods have been suggested, with most of them relying on statistical regression models. Given the known limitations of classical methods, approaches with the machine-learning have also become favorable. Among them, the multifactor dimensionality reduction (MDR), a powerful statistical tool for detecting and modeling epistasis, has been widely applied (<xref ref-type="bibr" rid="B114">Ritchie et al., 2001</xref>). Polygenic risk score is another approach to summarize the additive trait variance captured by a set of genetic markers that do not individually achieve significance in a large-scale association study (<xref ref-type="bibr" rid="B5">Baker et al., 2018</xref>).</p>
</sec>
<sec>
<title>Interaction Between <italic>BDNF</italic> Val66Met Polymorphism and Environmental Factors</title>
<p>Evidence suggests that interactions between genes and the environment influence brain development and the risk of neuropsychiatric diseases (<xref ref-type="bibr" rid="B68">Keverne, 2014</xref>; <xref ref-type="bibr" rid="B9">Booij et al., 2015</xref>; <xref ref-type="bibr" rid="B80">Lin et al., 2017</xref>; <xref ref-type="bibr" rid="B91">Misiak et al., 2017</xref>). Many environmental factors (such as prenatal adverse environments, childhood trauma, weather and life stress) have been found to play an important role in the causality of brain diseases.</p>
<p>The <italic>BDNF</italic> Val66Met polymorphism has been reported to interact with early life stress; thus, Val carriers with childhood trauma are more susceptible to the occurrence of subclinical psychotic experiences (<xref ref-type="bibr" rid="B25">de Castro-Catala et al., 2016</xref>). Another study in subjects with the schizophrenia spectrum or bipolar disorder demonstrated that Met carriers with high levels of childhood trauma have significantly low levels of blood <italic>BDNF</italic> mRNA and decreased CA2/3 and CA4 subfield areas in the dentate gyrus (<xref ref-type="bibr" rid="B1">Aas et al., 2014</xref>).</p>
<p>The <italic>BDNF</italic> Val66Met polymorphism has been long considered an important candidate for reducing depression risk; however, inconsistent findings have been obtained. A meta-analysis with a pooled total of 14,233 participants found that the Met allele significantly moderates the link between life stress and depression risk (<xref ref-type="bibr" rid="B54">Hosang et al., 2014</xref>). When stratified by the type of environmental stressor, the interaction between the <italic>BDNF</italic> Val66Met polymorphism and life stress in depression became stronger for stressful life events rather than for childhood adversity. The findings were replicated by a recent meta-analysis of 31 studies, involving of 21,060 participants, providing further evidence for an interaction between the <italic>BDNF</italic> Val66Met polymorphism and life stress in depression (<xref ref-type="bibr" rid="B168">Zhao M. et al., 2017</xref>).</p>
<p>Epigenetic studies have suggested that histone modifications, DNA methylation, and hydroxymethylation are possible mediators linking individual response to environmental factors and brain diseases (<xref ref-type="bibr" rid="B90">McEwen et al., 2015</xref>). These mediators may change the pattern of gene expression, influencing protein levels and ultimately shaping phenotypes during the life span. A study evaluating <italic>BDNF</italic> Val66Met polymorphism methylation in the peripheral blood of healthy subjects demonstrated that the increased methylation was associated with hypoxia-related early life events and impaired working memory in Val/Val individuals, and the opposite was true for Val/Met individuals (<xref ref-type="bibr" rid="B148">Ursini et al., 2016</xref>).</p>
<p>The interplay of genetic, epigenetic, and environmental factors may influence cognitive function. A study in normal subjects and subjects with amnestic mild cognitive impairment (aMCI) demonstrated that the increased <italic>BDNF</italic> promoter methylation status was associated with aMCI and its progression to AD (<xref ref-type="bibr" rid="B158">Xie et al., 2017</xref>). The interaction between DNA methylation and Met homozygosity increased the risk of aMCI and its progression to AD.</p>
<p>An epigenetic study of anxiety/depression in older women found higher <italic>BDNF</italic> DNA methylation in subjects with anxiety/depression than in controls, and this difference was more pronounced in <italic>BDNF</italic> Val66Met heterozygotes than in Val homozygotes (<xref ref-type="bibr" rid="B16">Chagnon et al., 2015</xref>).</p>
<p>It should be noted that, in terms of the two-hit hypothesis, there are studies which show that a second hit actually led to improvements, and some genetic polymorphisms, including <italic>BDNF</italic> Val66Met polymorphism, may actually increase resilience. For example, a recent study showed that <italic>BDNF</italic><sup>Met/Met</sup> transgenic mice had spatial and fear-associated memory deficits, but corticosterone treatment recovered this phenotype (<xref ref-type="bibr" rid="B99">Notaras et al., 2017</xref>).</p>
</sec>
<sec>
<title><italic>BDNF</italic><sup>Met/Met</sup> Transgenic Mice</title>
<p><xref ref-type="bibr" rid="B21">Chen et al. (2006)</xref> generated an inbred genetic knock-in mouse (<italic>BDNF</italic><sup>Met/Met</sup>) that recapitulates the phenotypic hallmarks of human carriers with the Met allele. <italic>BDNF</italic><sup>Met/Met</sup> mice represent a potential model to study the biological mechanism of this polymorphism in the brain.</p>
<p><italic>BDNF</italic><sup>Met/Met</sup> mice had decreased basal BDNF protein levels in the hippocampus, which could not be normalized by antidepressant (fluoxetine) administration (<xref ref-type="bibr" rid="B7">Bath et al., 2012b</xref>). <italic>BDNF</italic><sup>Met/Met</sup> mice also showed impaired survival of newly generated cells and LTP in the dentate gyrus (<xref ref-type="bibr" rid="B7">Bath et al., 2012b</xref>). A recent study demonstrated that <italic>BDNF</italic><sup>Met/Met</sup> mice exhibited diminished development of serotonergic fibers projecting particularly to the prefrontal cortex compared with wild-type mice; this diminished development was rescued by fluoxetine administration during peri-adolescence (<xref ref-type="bibr" rid="B27">Dincheva et al., 2017</xref>).</p>
<p>Compared with wild-type mice, significant decreases of 13.7% ± 0.7% and 14.4% ± 0.7% were observed in the hippocampal volume of <italic>BDNF</italic><sup>+/Met</sup> and <italic>BDNF</italic><sup>Met/Met</sup> mice, respectively (<xref ref-type="bibr" rid="B21">Chen et al., 2006</xref>). The transgenic mice showed increased depression and anxiety-like behaviors in stressful settings, and the behaviors were not normalized by antidepressant (fluoxetine) administration (<xref ref-type="bibr" rid="B21">Chen et al., 2006</xref>; <xref ref-type="bibr" rid="B165">Yu et al., 2012</xref>). In addition, the variant mice showed impaired learning of cues that signal safety (<xref ref-type="bibr" rid="B120">Soliman et al., 2010</xref>). These findings provide an example of a human genetic variant that has been modeled in transgenic mice can produce similar phenotypic hallmarks observed in some clinical studies.</p>
<p>The aforementioned findings should be interpreted with caution because not all findings demonstrated in <italic>BDNF</italic><sup>Met/Met</sup> mice have been consistently found in human studies. For example, <italic>BDNF</italic><sup>Met/Met</sup> mice had a decreased hippocampal volume compared with that of wild-type mice (<xref ref-type="bibr" rid="B21">Chen et al., 2006</xref>). An earlier report also showed that human Met carriers had reduced hippocampal gray matter volume compared with that of Val homozygotes (<xref ref-type="bibr" rid="B107">Pezawas et al., 2004</xref>). However, following imaging genetic studies have shown controversial results regarding the genetic effect of <italic>BDNF</italic> Val66Met on hippocampal volumes in normal subjects (<xref ref-type="bibr" rid="B46">Harrisberger et al., 2014</xref>; <xref ref-type="bibr" rid="B83">Liu et al., 2014</xref>). A meta-analysis including 5,298 healthy subjects revealed no significant <italic>BDNF</italic> genotype effect on hippocampal volume (<xref ref-type="bibr" rid="B46">Harrisberger et al., 2014</xref>).</p>
<p>Another example is the genetic association studies of the <italic>BDNF</italic> Val66Met polymorphism and cognitive function, which has been the focus of several clinical studies. Cognitive impairment has been reported in a mouse model of the <italic>BDNF</italic> Met allele (<xref ref-type="bibr" rid="B21">Chen et al., 2006</xref>; <xref ref-type="bibr" rid="B26">Dincheva et al., 2012</xref>). Conflicting findings have been obtained for the genetic effect of <italic>BDNF</italic> Val66Met on human cognitive function (<xref ref-type="bibr" rid="B145">Tsai et al., 2004b</xref>, <xref ref-type="bibr" rid="B139">2008a</xref>; <xref ref-type="bibr" rid="B52">Hong et al., 2011</xref>). A meta-analysis including 7,095 individuals failed to support significant genetic associations between the Val66Met polymorphism and any of the cognitive phenotypes (<xref ref-type="bibr" rid="B88">Mandelman and Grigorenko, 2012</xref>).</p>
<p>Brain-derived neurotrophic factor has been implicated in the pathogenesis of major depression (<xref ref-type="bibr" rid="B28">Duman et al., 1997</xref>; <xref ref-type="bibr" rid="B140">Tsai et al., 2008b</xref>). Animal studies have demonstrated that <italic>BDNF</italic><sup>Met/Met</sup> mice exhibited depression-like behaviors in stressful situations (<xref ref-type="bibr" rid="B21">Chen et al., 2006</xref>; <xref ref-type="bibr" rid="B165">Yu et al., 2012</xref>). However, in clinical studies, we found the Met allele is not associated with depression in either psychiatric outpatients or inpatients (<xref ref-type="bibr" rid="B51">Hong et al., 2003a</xref>; <xref ref-type="bibr" rid="B138">Tsai et al., 2003</xref>).</p>
<p>Finally, it should be noted that the knock-in mouse model developed by the Lee group simply replaced the valine (which in rodents is in position 68, not 66) with a methionine (<xref ref-type="bibr" rid="B21">Chen et al., 2006</xref>). Recently the Ron research team generated another transgenic mice carrying the mouse homolog of the human <italic>BDNF</italic> Met allele (Met68<italic>BDNF</italic>) (<xref ref-type="bibr" rid="B155">Warnault et al., 2016</xref>). Using this model, they demonstrated that Met allele increases the risk of compulsive alcohol drinking which can be reversed by directly activating the TrkB receptor (<xref ref-type="bibr" rid="B155">Warnault et al., 2016</xref>).</p>
<p>It is not known if and how this slight difference with the human <italic>BDNF</italic> Val66Met polymorphism affects the validity of these mouse models. A more precise transgenic model was developed by the Gogos group, where the mice were ‘humanized’ by inserting a small stretch of human sequence, including Val/Met at position 66 (<xref ref-type="bibr" rid="B14">Cao et al., 2007</xref>). This genetic manipulation generated knock-in alleles that express human <italic>BDNF</italic> genes controlled by endogenous mouse <italic>Bdnf</italic> regulatory elements. This one has now been used by several other investigators. For example, recent studies using this <italic>hBDNF</italic><sup>V al66Met</sup> knock-in mice, <xref ref-type="bibr" rid="B149">van den Buuse et al. (2017)</xref> showed that the <italic>BDNF</italic> Val66Met Val/Met and Met/Met genotypes are more sensitive than the Val/Val genotype to the effect of apomorphine on prepulse inhibition. A history of stress, modeled by long-term treatment with corticosterone in young adults, increases the effects of apomorphine in Val/Val mice (<xref ref-type="bibr" rid="B149">van den Buuse et al., 2017</xref>).</p>
</sec>
<sec>
<title>Findings of the Novel Function of <italic>BDNF</italic> Val66Met Polymorphism</title>
<p>The first study investigating the function of this polymorphism demonstrated that <italic>BDNF</italic> Val66Met polymorphism affects activity-dependent BDNF release (<xref ref-type="bibr" rid="B29">Egan et al., 2003</xref>). In addition to this genetic effect, recent studies have found more functional effects for this polymorphism.</p>
<p>Brain-derived neurotrophic factor is initially synthesized as the precursor protein proBDNF, which is then cleaved by intracellular (furin/PC1) or extracellular peptidase enzymes (tPA/plasmin/MMP) into bioactive mature BDNF and pro-peptide (or pro-domain) (<xref ref-type="bibr" rid="B103">Pang et al., 2004</xref>). The Val66Met substitution is present in the BDNF pro-peptide region. The BDNF pro-peptide is detected in the hippocampus, and the application of the Met-type, but not Val-type, BDNF pro-peptide can induce acute growth cone retraction, suggesting that the Met-type pro-peptide is a new active ligand that can modulate neuronal morphology (<xref ref-type="bibr" rid="B2">Anastasia et al., 2013</xref>).</p>
<p>The BDNF pro-peptide functions as a modulator of synaptic plasticity by enhancing hippocampal long-term depression (LTD) (<xref ref-type="bibr" rid="B93">Mizui et al., 2015</xref>). Mizui et al. found that the Val-type BDNF pro-peptide facilitates low-frequency stimulation–induced hippocampal LTD, whereas the Met-type pro-peptide attenuates LTD (<xref ref-type="bibr" rid="B93">Mizui et al., 2015</xref>).</p>
<p>The BDNF pro-peptide can bind to mature BDNF with high affinity, and compared with the complex with the Val-type pro-peptide, the complex with the Met-type pro-peptide is more stable, suggesting that the <italic>BDNF</italic> Val66Met polymorphism affects the stability of the complex formed between BDNF and its pro-peptide (<xref ref-type="bibr" rid="B147">Uegaki et al., 2017</xref>).</p>
<p>The <italic>BDNF</italic> Val66Met polymorphism may affect the protein or mRNA expression of BDNF. The effect of the Val66Met polymorphism on the constitutive expression of BDNF was tested in HEK293T cells transiently transfected with recombinant plasmids to induce overexpression of either the Val or Met variant (<xref ref-type="bibr" rid="B61">Jin et al., 2015</xref>). A significant decrease in secreted BDNF protein levels in the culture supernatants of cells overexpressing the Met variant was found. In the same study, Met carriers had increased blood <italic>BDNF</italic> mRNA and protein levels. A higher circulating BDNF concentration associated with the Met allele was also found in a large cohort (<xref ref-type="bibr" rid="B63">Kaess et al., 2015</xref>), but a negative association was also found (<xref ref-type="bibr" rid="B59">Jiang et al., 2009</xref>). In a meta-analysis, no association was found between serum BDNF levels and the Val66Met polymorphism (<xref ref-type="bibr" rid="B123">Terracciano et al., 2013</xref>).</p>
</sec>
<sec>
<title>Is Met or Val the Risk Allele?</title>
<p>The <italic>BDNF</italic> Val66Met polymorphism has been reported to be associated with psychiatric disorders, including obsessive-compulsive disorder, schizophrenia, psychosis, major depression, anxiety, and eating disorders (<xref ref-type="bibr" rid="B52">Hong et al., 2011</xref>; <xref ref-type="bibr" rid="B101">Notaras et al., 2015b</xref>). Most positive association studies have reported that the Met allele is the risk allele for psychiatric disease given that Met carriers exhibit reduced activity-dependent secretion of BDNF (<bold>Table <xref ref-type="table" rid="T1">1</xref></bold>). However, the higher activity <italic>BDNF</italic> Val allele is associated with bipolar disorder (<xref ref-type="bibr" rid="B98">Neves-Pereira et al., 2002</xref>; <xref ref-type="bibr" rid="B119">Sklar et al., 2002</xref>) and substance use disorder (<xref ref-type="bibr" rid="B22">Cheng et al., 2005</xref>; <xref ref-type="bibr" rid="B84">Liu et al., 2005</xref>; <xref ref-type="bibr" rid="B118">Sim et al., 2010</xref>). In the Mexican–American population, it has been found that individuals homozygous for the Val allele have an increased chance of depression (<xref ref-type="bibr" rid="B113">Ribeiro et al., 2007</xref>). These findings suggest that this <italic>BDNF</italic> polymorphism has pleiotropic effects on multiple phenotypes; thus, this polymorphism imparts separate advantageous traits and disadvantageous traits in the same organism.</p>
<p>The different effects of this polymorphism in different disorders here could be due to the differential expression of BDNF and its receptor in different regions of the brain. For example, over or under activity-dependent secretion of BDNF will have varying effects on amygdala related behaviors (e.g., fear/anxiety) when compared with cognition (hippocampal-dependent) (<xref ref-type="bibr" rid="B3">Andero et al., 2014</xref>; <xref ref-type="bibr" rid="B57">Ilchibaeva et al., 2018</xref>).</p>
<p>Furthermore, evidence suggests that increased BDNF activity has a deleterious effect and may be implicated in the pathogenesis of some diseases (<xref ref-type="bibr" rid="B131">Tsai, 2005</xref>, <xref ref-type="bibr" rid="B132">2006</xref>, <xref ref-type="bibr" rid="B133">2007a</xref>,<xref ref-type="bibr" rid="B135">c</xref>). For example, increased BDNF activity in the ventral tegmental area-nucleus accumbens (VTA-NAc) pathway may be implicated in the pathogenesis of major depression (<xref ref-type="bibr" rid="B30">Eisch et al., 2003</xref>). Evidence also suggests that BDNF overactivity in the brain may be implicated in the pathogenesis of bipolar disorder (<xref ref-type="bibr" rid="B130">Tsai, 2004b</xref>), substance abuse (<xref ref-type="bibr" rid="B133">Tsai, 2007a</xref>), and autism (<xref ref-type="bibr" rid="B131">Tsai, 2005</xref>). Moreover, the genetic overexpression of the BDNF mature isoform in female mice impaired working memory functions, reduced breeding efficiency, increased anxiety-like behaviors, impaired prepulse inhibition, and elicited higher susceptibility to seizures (<xref ref-type="bibr" rid="B40">Govindarajan et al., 2006</xref>; <xref ref-type="bibr" rid="B104">Papaleo et al., 2011</xref>). Thus, the Val allele, which is associated with the increased activity-dependent secretion of BDNF, may be the risk allele for some neuropsychiatric diseases.</p>
</sec>
<sec>
<title>Other <italic>BDNF</italic> Polymorphisms</title>
<p>Investigating a single <italic>BDNF</italic> polymorphism (i.e., the Val66Met polymorphism) might only reveal some of the <italic>BDNF</italic> genetic variability and result in the overlooking of some information from other <italic>BDNF</italic> SNPs (<xref ref-type="bibr" rid="B141">Tsai et al., 2010</xref>; <xref ref-type="bibr" rid="B164">Yeh et al., 2015</xref>). Furthermore, the use of a haplotype constructed by several tag <italic>BDNF</italic> SNPs can improve genotyping efficiency by reducing the number of polymorphisms to be genotyped, and the haplotype itself may also tag other genetic variants that affect gene function.</p>
<p>Genetic studies of other <italic>BDNF</italic> polymorphisms have been conducted. For example, <xref ref-type="bibr" rid="B109">Proschel et al. (1992)</xref> identified a dinucleotide repeat polymorphism (GT) that maps 1,040 bp upstream from the transcription start site (<xref ref-type="bibr" rid="B109">Proschel et al., 1992</xref>). The <italic>BDNF</italic> GT repeat polymorphism is associated with age at onset, therapeutic response, susceptibility, and chlorpromazine-induced extrapyramidal syndrome in schizophrenia (<xref ref-type="bibr" rid="B71">Krebs et al., 2000</xref>; <xref ref-type="bibr" rid="B160">Xu et al., 2008</xref>).</p>
<p>Another common <italic>BDNF</italic> SNP, namely the C270T polymorphism (rs56164415) in the <italic>BDNF</italic> 5′ non-coding region, has been identified and reported to be associated with AD (<xref ref-type="bibr" rid="B72">Kunugi et al., 2001</xref>).</p>
<p>By sequencing the entire <italic>BDNF</italic> gene and the 5-kb flanking region, <xref ref-type="bibr" rid="B78">Licinio et al. (2009)</xref> demonstrated that six <italic>BDNF</italic> SNPs (rs12273539, rs11030103, rs6265, rs28722151, rs41282918, and rs11030101) are significantly associated with MDD.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>Considering the important role of BDNF in the brain and the functional effect of the common <italic>BDNF</italic> Val66Met polymorphism, this polymorphism is one of the most studied polymorphisms in neuropsychiatric diseases. However, following studies have been unable to replicate most positive findings in initial genetic studies. In this review, we highlighted critical issues in <italic>BDNF</italic> Val66Met studies, which may affect the findings of these studies. Most neuropsychiatric diseases are complex diseases that are dependent on many genetic and environmental factors that cannot be analyzed by conventional genetic association studies. Future studies should analyze various <italic>BDNF</italic> polymorphisms and these related factors by using machine learning techniques to accurately understand the genetic effect of <italic>BDNF</italic> on disease pathogenesis.</p>
</sec>
<sec>
<title>Author Contributions</title>
<p>The author confirms being the sole contributor of this work and approved it for publication.</p>
</sec>
<sec>
<title>Conflict of Interest Statement</title>
<p>The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This work was supported by grant MOST 107-2634-F-075-002 and MOST 104-2745-B-075-002 from Taiwan Ministry of Science and Technology, and grants V105E17-002-MY2-1, V105D17-002-MY2-2, and VGHUST103-G1-4-1 from the Taipei Veterans General Hospital.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aas</surname><given-names>M.</given-names></name><name><surname>Haukvik</surname><given-names>U. K.</given-names></name><name><surname>Djurovic</surname><given-names>S.</given-names></name><name><surname>Tesli</surname><given-names>M.</given-names></name><name><surname>Athanasiu</surname><given-names>L.</given-names></name><name><surname>Bjella</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Interplay between childhood trauma and BDNF val66met variants on blood BDNF mRNA levels and on hippocampus subfields volumes in schizophrenia spectrum and bipolar disorders.</article-title>
<volume>59</volume>
<fpage>14</fpage>–<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpsychires.2014.08.011</pub-id>
<pub-id pub-id-type="pmid">25246365</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anastasia</surname><given-names>A.</given-names></name><name><surname>Deinhardt</surname><given-names>K.</given-names></name><name><surname>Chao</surname><given-names>M. V.</given-names></name><name><surname>Will</surname><given-names>N. E.</given-names></name><name><surname>Irmady</surname><given-names>K.</given-names></name><name><surname>Lee</surname><given-names>F. S.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Val66Met polymorphism of BDNF alters prodomain structure to induce neuronal growth cone retraction.</article-title>
<volume>4</volume>:<issue>2490</issue>. <pub-id pub-id-type="doi">10.1038/ncomms3490</pub-id>
<pub-id pub-id-type="pmid">24048383</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andero</surname><given-names>R.</given-names></name><name><surname>Choi</surname><given-names>D. C.</given-names></name><name><surname>Ressler</surname><given-names>K. J.</given-names></name></person-group> (<year>2014</year>). <article-title>BDNF-TrkB receptor regulation of distributed adult neural plasticity, memory formation, and psychiatric disorders.</article-title>
<volume>122</volume>
<fpage>169</fpage>–<lpage>192</lpage>. <pub-id pub-id-type="doi">10.1016/B978-0-12-420170-5.00006-4</pub-id>
<pub-id pub-id-type="pmid">24484701</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atwi</surname><given-names>S.</given-names></name><name><surname>Mcmahon</surname><given-names>D.</given-names></name><name><surname>Scharfman</surname><given-names>H.</given-names></name><name><surname>Maclusky</surname><given-names>N. J.</given-names></name></person-group> (<year>2016</year>). <article-title>Androgen modulation of hippocampal structure and function.</article-title>
<volume>22</volume>
<fpage>46</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1177/1073858414558065</pub-id>
<pub-id pub-id-type="pmid">25416742</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname><given-names>E.</given-names></name><name><surname>Schmidt</surname><given-names>K. M.</given-names></name><name><surname>Sims</surname><given-names>R.</given-names></name><name><surname>O’donovan</surname><given-names>M. C.</given-names></name><name><surname>Williams</surname><given-names>J.</given-names></name><name><surname>Holmans</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2018</year>). <article-title>POLARIS: polygenic LD-adjusted risk score approach for set-based analysis of GWAS data.</article-title>
<pub-id pub-id-type="doi">10.1002/gepi.22117</pub-id>
<comment>[Epub ahead of print]</comment>. <pub-id pub-id-type="pmid">29532500</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bath</surname><given-names>K. G.</given-names></name><name><surname>Chuang</surname><given-names>J.</given-names></name><name><surname>Spencer-Segal</surname><given-names>J. L.</given-names></name><name><surname>Amso</surname><given-names>D.</given-names></name><name><surname>Altemus</surname><given-names>M.</given-names></name><name><surname>Mcewen</surname><given-names>B. S.</given-names></name><etal></etal></person-group> (<year>2012a</year>). <article-title>Variant brain-derived neurotrophic factor (Valine66Methionine) polymorphism contributes to developmental and estrous stage-specific expression of anxiety-like behavior in female mice.</article-title>
<volume>72</volume>
<fpage>499</fpage>–<lpage>504</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2012.03.032</pub-id>
<pub-id pub-id-type="pmid">22552045</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bath</surname><given-names>K. G.</given-names></name><name><surname>Jing</surname><given-names>D. Q.</given-names></name><name><surname>Dincheva</surname><given-names>I.</given-names></name><name><surname>Neeb</surname><given-names>C. C.</given-names></name><name><surname>Pattwell</surname><given-names>S. S.</given-names></name><name><surname>Chao</surname><given-names>M. V.</given-names></name><etal></etal></person-group> (<year>2012b</year>). <article-title>BDNF Val66Met impairs fluoxetine-induced enhancement of adult hippocampus plasticity.</article-title>
<volume>37</volume>
<fpage>1297</fpage>–<lpage>1304</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2011.318</pub-id>
<pub-id pub-id-type="pmid">22218094</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Begliuomini</surname><given-names>S.</given-names></name><name><surname>Casarosa</surname><given-names>E.</given-names></name><name><surname>Pluchino</surname><given-names>N.</given-names></name><name><surname>Lenzi</surname><given-names>E.</given-names></name><name><surname>Centofanti</surname><given-names>M.</given-names></name><name><surname>Freschi</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Influence of endogenous and exogenous sex hormones on plasma brain-derived neurotrophic factor.</article-title>
<volume>22</volume>
<fpage>995</fpage>–<lpage>1002</lpage>. <pub-id pub-id-type="doi">10.1093/humrep/del479</pub-id>
<pub-id pub-id-type="pmid">17251358</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Booij</surname><given-names>L.</given-names></name><name><surname>Tremblay</surname><given-names>R. E.</given-names></name><name><surname>Szyf</surname><given-names>M.</given-names></name><name><surname>Benkelfat</surname><given-names>C.</given-names></name></person-group> (<year>2015</year>). <article-title>Genetic and early environmental influences on the serotonin system: consequences for brain development and risk for psychopathology.</article-title>
<volume>40</volume>
<fpage>5</fpage>–<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1503/jpn.140099</pub-id>
<pub-id pub-id-type="pmid">25285876</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bramham</surname><given-names>C. R.</given-names></name><name><surname>Messaoudi</surname><given-names>E.</given-names></name></person-group> (<year>2005</year>). <article-title>BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis.</article-title>
<volume>76</volume>
<fpage>99</fpage>–<lpage>125</lpage>. <pub-id pub-id-type="doi">10.1016/j.pneurobio.2005.06.003</pub-id>
<pub-id pub-id-type="pmid">16099088</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brandys</surname><given-names>M. K.</given-names></name><name><surname>Kas</surname><given-names>M. J.</given-names></name><name><surname>Van Elburg</surname><given-names>A. A.</given-names></name><name><surname>Ophoff</surname><given-names>R.</given-names></name><name><surname>Slof-Op’t Landt</surname><given-names>M. C.</given-names></name><name><surname>Middeldorp</surname><given-names>C. M.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>The Val66Met polymorphism of the BDNF gene in anorexia nervosa: new data and a meta-analysis.</article-title>
<volume>14</volume>
<fpage>441</fpage>–<lpage>451</lpage>. <pub-id pub-id-type="doi">10.3109/15622975.2011.605470</pub-id>
<pub-id pub-id-type="pmid">21936709</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruenig</surname><given-names>D.</given-names></name><name><surname>Lurie</surname><given-names>J.</given-names></name><name><surname>Morris</surname><given-names>C. P.</given-names></name><name><surname>Harvey</surname><given-names>W.</given-names></name><name><surname>Lawford</surname><given-names>B.</given-names></name><name><surname>Young</surname><given-names>R. M.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>A case-control study and meta-analysis reveal BDNF Val66Met is a possible risk factor for PTSD.</article-title>
<volume>2016</volume>:<issue>6979435</issue>. <pub-id pub-id-type="doi">10.1155/2016/6979435</pub-id>
<pub-id pub-id-type="pmid">27413557</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>X.</given-names></name><name><surname>Shi</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>A.</given-names></name><name><surname>Zheng</surname><given-names>M.</given-names></name><name><surname>Fang</surname><given-names>Y.</given-names></name></person-group> (<year>2017</year>). <article-title>The association between brain-derived neurotrophic factor gene polymorphism and migraine: a meta-analysis.</article-title>
<volume>18</volume>:<issue>13</issue>. <pub-id pub-id-type="doi">10.1186/s10194-017-0725-2</pub-id>
<pub-id pub-id-type="pmid">28150221</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>L.</given-names></name><name><surname>Dhilla</surname><given-names>A.</given-names></name><name><surname>Mukai</surname><given-names>J.</given-names></name><name><surname>Blazeski</surname><given-names>R.</given-names></name><name><surname>Lodovichi</surname><given-names>C.</given-names></name><name><surname>Mason</surname><given-names>C. A.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Genetic modulation of BDNF signaling affects the outcome of axonal competition in vivo.</article-title>
<volume>17</volume>
<fpage>911</fpage>–<lpage>921</lpage>. <pub-id pub-id-type="doi">10.1016/j.cub.2007.04.040</pub-id>
<pub-id pub-id-type="pmid">17493809</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cargnin</surname><given-names>S.</given-names></name><name><surname>Massarotti</surname><given-names>A.</given-names></name><name><surname>Terrazzino</surname><given-names>S.</given-names></name></person-group> (<year>2016</year>). <article-title>BDNF Val66Met and clinical response to antipsychotic drugs: a systematic review and meta-analysis.</article-title>
<volume>33</volume>
<fpage>45</fpage>–<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1016/j.eurpsy.2015.12.001</pub-id>
<pub-id pub-id-type="pmid">26854986</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chagnon</surname><given-names>Y. C.</given-names></name><name><surname>Potvin</surname><given-names>O.</given-names></name><name><surname>Hudon</surname><given-names>C.</given-names></name><name><surname>Preville</surname><given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>DNA methylation and single nucleotide variants in the brain-derived neurotrophic factor (BDNF) and oxytocin receptor (OXTR) genes are associated with anxiety/depression in older women.</article-title>
<volume>6</volume>:<issue>230</issue>. <pub-id pub-id-type="doi">10.3389/fgene.2015.00230</pub-id>
<pub-id pub-id-type="pmid">26175754</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>C. B.</given-names></name><name><surname>Ye</surname><given-names>K.</given-names></name></person-group> (<year>2017</year>). <article-title>Sex differences in brain-derived neurotrophic factor signaling and functions.</article-title>
<volume>95</volume>
<fpage>328</fpage>–<lpage>335</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.23863</pub-id>
<pub-id pub-id-type="pmid">27870419</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>C. C.</given-names></name><name><surname>Chang</surname><given-names>H. A.</given-names></name><name><surname>Chen</surname><given-names>T. Y.</given-names></name><name><surname>Fang</surname><given-names>W. H.</given-names></name><name><surname>Huang</surname><given-names>S. Y.</given-names></name></person-group> (<year>2014</year>). <article-title>Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism affects sympathetic tone in a gender-specific way.</article-title>
<volume>47</volume>
<fpage>17</fpage>–<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1016/j.psyneuen.2014.04.019</pub-id>
<pub-id pub-id-type="pmid">25001952</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>K.</given-names></name><name><surname>Wang</surname><given-names>N.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Hong</surname><given-names>X.</given-names></name><name><surname>Xu</surname><given-names>H.</given-names></name><name><surname>Zhao</surname><given-names>X.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Is the Val66Met polymorphism of the brain-derived neurotrophic factor gene associated with panic disorder? A meta-analysis.</article-title>
<volume>9</volume>:<issue>e12228</issue>. <pub-id pub-id-type="doi">10.1111/appy.12228</pub-id>
<pub-id pub-id-type="pmid">26687639</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>M. H.</given-names></name><name><surname>Tsai</surname><given-names>S. J.</given-names></name></person-group> (<year>2016</year>). <article-title>Treatment-resistant panic disorder: clinical significance, concept and management.</article-title>
<volume>70</volume>
<fpage>219</fpage>–<lpage>226</lpage>. <pub-id pub-id-type="doi">10.1016/j.pnpbp.2016.02.001</pub-id>
<pub-id pub-id-type="pmid">26850787</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Z. Y.</given-names></name><name><surname>Jing</surname><given-names>D.</given-names></name><name><surname>Bath</surname><given-names>K. G.</given-names></name><name><surname>Ieraci</surname><given-names>A.</given-names></name><name><surname>Khan</surname><given-names>T.</given-names></name><name><surname>Siao</surname><given-names>C. J.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior.</article-title>
<volume>314</volume>
<fpage>140</fpage>–<lpage>143</lpage>. <pub-id pub-id-type="doi">10.1126/science.1129663</pub-id>
<pub-id pub-id-type="pmid">17023662</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>C. Y.</given-names></name><name><surname>Hong</surname><given-names>C. J.</given-names></name><name><surname>Yu</surname><given-names>Y. W.</given-names></name><name><surname>Chen</surname><given-names>T. J.</given-names></name><name><surname>Wu</surname><given-names>H. C.</given-names></name><name><surname>Tsai</surname><given-names>S. J.</given-names></name></person-group> (<year>2005</year>). <article-title>Brain-derived neurotrophic factor (Val66Met) genetic polymorphism is associated with substance abuse in males.</article-title>
<volume>140</volume>
<fpage>86</fpage>–<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/j.molbrainres.2005.07.008</pub-id>
<pub-id pub-id-type="pmid">16109452</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>S. C.</given-names></name><name><surname>Kim</surname><given-names>H. W.</given-names></name><name><surname>Kim</surname><given-names>B. N.</given-names></name><name><surname>Kim</surname><given-names>J. W.</given-names></name><name><surname>Shin</surname><given-names>M. S.</given-names></name><name><surname>Chung</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Gender-specific association of the brain-derived neurotrophic factor gene with attention-deficit/hyperactivity disorder.</article-title>
<volume>7</volume>
<fpage>285</fpage>–<lpage>290</lpage>. <pub-id pub-id-type="doi">10.4306/pi.2010.7.4.285</pub-id>
<pub-id pub-id-type="pmid">21253413</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname><given-names>L.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name><name><surname>Meng</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>K.</given-names></name><name><surname>Fu</surname><given-names>L.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Association between the BDNF G196A and C270T polymorphisms and Parkinson’s disease: a meta-analysis.</article-title>
<volume>123</volume>
<fpage>675</fpage>–<lpage>683</lpage>. <pub-id pub-id-type="doi">10.3109/00207454.2013.798784</pub-id>
<pub-id pub-id-type="pmid">23611539</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Castro-Catala</surname><given-names>M.</given-names></name><name><surname>Van Nierop</surname><given-names>M.</given-names></name><name><surname>Barrantes-Vidal</surname><given-names>N.</given-names></name><name><surname>Cristobal-Narvaez</surname><given-names>P.</given-names></name><name><surname>Sheinbaum</surname><given-names>T.</given-names></name><name><surname>Kwapil</surname><given-names>T. R.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Childhood trauma, BDNF Val66Met and subclinical psychotic experiences. Attempt at replication in two independent samples.</article-title>
<volume>83</volume>
<fpage>121</fpage>–<lpage>129</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpsychires.2016.08.014</pub-id>
<pub-id pub-id-type="pmid">27596955</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dincheva</surname><given-names>I.</given-names></name><name><surname>Glatt</surname><given-names>C. E.</given-names></name><name><surname>Lee</surname><given-names>F. S.</given-names></name></person-group> (<year>2012</year>). <article-title>Impact of the BDNF Val66Met polymorphism on cognition: implications for behavioral genetics.</article-title>
<volume>18</volume>
<fpage>439</fpage>–<lpage>451</lpage>. <pub-id pub-id-type="doi">10.1177/1073858411431646</pub-id>
<pub-id pub-id-type="pmid">22367929</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dincheva</surname><given-names>I.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>A.</given-names></name><name><surname>Marinic</surname><given-names>T.</given-names></name><name><surname>Freilingsdorf</surname><given-names>H.</given-names></name><name><surname>Huang</surname><given-names>C.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Effect of early-life fluoxetine on anxiety-like behaviors in BDNF Val66Met Mice.</article-title>
<volume>174</volume>
<fpage>1203</fpage>–<lpage>1213</lpage>. <pub-id pub-id-type="doi">10.1176/appi.ajp.2017.15121592</pub-id>
<pub-id pub-id-type="pmid">29084453</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duman</surname><given-names>R. S.</given-names></name><name><surname>Heninger</surname><given-names>G. R.</given-names></name><name><surname>Nestler</surname><given-names>E. J.</given-names></name></person-group> (<year>1997</year>). <article-title>A molecular and cellular theory of depression.</article-title>
<volume>54</volume>
<fpage>597</fpage>–<lpage>606</lpage>. <pub-id pub-id-type="doi">10.1001/archpsyc.1997.01830190015002</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egan</surname><given-names>M. F.</given-names></name><name><surname>Kojima</surname><given-names>M.</given-names></name><name><surname>Callicott</surname><given-names>J. H.</given-names></name><name><surname>Goldberg</surname><given-names>T. E.</given-names></name><name><surname>Kolachana</surname><given-names>B. S.</given-names></name><name><surname>Bertolino</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function.</article-title>
<volume>112</volume>
<fpage>257</fpage>–<lpage>269</lpage>. <pub-id pub-id-type="doi">10.1016/S0092-8674(03)00035-7</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eisch</surname><given-names>A. J.</given-names></name><name><surname>Bolanos</surname><given-names>C. A.</given-names></name><name><surname>De Wit</surname><given-names>J.</given-names></name><name><surname>Simonak</surname><given-names>R. D.</given-names></name><name><surname>Pudiak</surname><given-names>C. M.</given-names></name><name><surname>Barrot</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Brain-derived neurotrophic factor in the ventral midbrain-nucleus accumbens pathway: a role in depression.</article-title>
<volume>54</volume>
<fpage>994</fpage>–<lpage>1005</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2003.08.003</pub-id>
<pub-id pub-id-type="pmid">14625141</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ernfors</surname><given-names>P.</given-names></name><name><surname>Lee</surname><given-names>K. F.</given-names></name><name><surname>Jaenisch</surname><given-names>R.</given-names></name></person-group> (<year>1994</year>). <article-title>Mice lacking brain-derived neurotrophic factor develop with sensory deficits.</article-title>
<volume>368</volume>
<fpage>147</fpage>–<lpage>150</lpage>. <pub-id pub-id-type="doi">10.1038/368147a0</pub-id>
<pub-id pub-id-type="pmid">8139657</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Failla</surname><given-names>M. D.</given-names></name><name><surname>Kumar</surname><given-names>R. G.</given-names></name><name><surname>Peitzman</surname><given-names>A. B.</given-names></name><name><surname>Conley</surname><given-names>Y. P.</given-names></name><name><surname>Ferrell</surname><given-names>R. E.</given-names></name><name><surname>Wagner</surname><given-names>A. K.</given-names></name></person-group> (<year>2015</year>). <article-title>Variation in the BDNF gene interacts with age to predict mortality in a prospective, longitudinal cohort with severe TBI.</article-title>
<volume>29</volume>
<fpage>234</fpage>–<lpage>246</lpage>. <pub-id pub-id-type="doi">10.1177/1545968314542617</pub-id>
<pub-id pub-id-type="pmid">25063686</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forero</surname><given-names>D. A.</given-names></name><name><surname>Lopez-Leon</surname><given-names>S.</given-names></name><name><surname>Shin</surname><given-names>H. D.</given-names></name><name><surname>Park</surname><given-names>B. L.</given-names></name><name><surname>Kim</surname><given-names>D. J.</given-names></name></person-group> (<year>2015</year>). <article-title>Meta-analysis of six genes (BDNF, DRD1, DRD3, DRD4, GRIN2B and MAOA) involved in neuroplasticity and the risk for alcohol dependence.</article-title>
<volume>149</volume>
<fpage>259</fpage>–<lpage>263</lpage>. <pub-id pub-id-type="doi">10.1016/j.drugalcdep.2015.01.017</pub-id>
<pub-id pub-id-type="pmid">25660313</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frustaci</surname><given-names>A.</given-names></name><name><surname>Pozzi</surname><given-names>G.</given-names></name><name><surname>Gianfagna</surname><given-names>F.</given-names></name><name><surname>Manzoli</surname><given-names>L.</given-names></name><name><surname>Boccia</surname><given-names>S.</given-names></name></person-group> (<year>2008</year>). <article-title>Meta-analysis of the brain-derived neurotrophic factor gene (BDNF) Val66Met polymorphism in anxiety disorders and anxiety-related personality traits.</article-title>
<volume>58</volume>
<fpage>163</fpage>–<lpage>170</lpage>. <pub-id pub-id-type="doi">10.1159/000182892</pub-id>
<pub-id pub-id-type="pmid">19088493</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukumoto</surname><given-names>N.</given-names></name><name><surname>Fujii</surname><given-names>T.</given-names></name><name><surname>Combarros</surname><given-names>O.</given-names></name><name><surname>Kamboh</surname><given-names>M. I.</given-names></name><name><surname>Tsai</surname><given-names>S. J.</given-names></name><name><surname>Matsushita</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Sexually dimorphic effect of the Val66Met polymorphism of BDNF on susceptibility to Alzheimer’s disease: new data and meta-analysis.</article-title>
<volume>153B</volume>
<fpage>235</fpage>–<lpage>242</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.b.30986</pub-id>
<pub-id pub-id-type="pmid">19504537</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibbs</surname><given-names>R. B.</given-names></name></person-group> (<year>1998</year>). <article-title>Levels of trkA and BDNF mRNA, but not NGF mRNA, fluctuate across the estrous cycle and increase in response to acute hormone replacement.</article-title>
<volume>787</volume>
<fpage>259</fpage>–<lpage>268</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-8993(97)01511-4</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez-Garre</surname><given-names>P.</given-names></name><name><surname>Huertas-Fernandez</surname><given-names>I.</given-names></name><name><surname>Caceres-Redondo</surname><given-names>M. T.</given-names></name><name><surname>Alonso-Canovas</surname><given-names>A.</given-names></name><name><surname>Bernal-Bernal</surname><given-names>I.</given-names></name><name><surname>Blanco-Ollero</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>BDNF Val66Met polymorphism in primary adult-onset dystonia: a case-control study and meta-analysis.</article-title>
<volume>29</volume>
<fpage>1083</fpage>–<lpage>1086</lpage>. <pub-id pub-id-type="doi">10.1002/mds.25938</pub-id>
<pub-id pub-id-type="pmid">24925604</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez-Castro</surname><given-names>T. B.</given-names></name><name><surname>Nicolini</surname><given-names>H.</given-names></name><name><surname>Lanzagorta</surname><given-names>N.</given-names></name><name><surname>Lopez-Narvaez</surname><given-names>L.</given-names></name><name><surname>Genis</surname><given-names>A.</given-names></name><name><surname>Pool Garcia</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>The role of brain-derived neurotrophic factor (BDNF) Val66Met genetic polymorphism in bipolar disorder: a case-control study, comorbidities, and meta-analysis of 16,786 subjects.</article-title>
<volume>17</volume>
<fpage>27</fpage>–<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1111/bdi.12227</pub-id>
<pub-id pub-id-type="pmid">25041243</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez-Castro</surname><given-names>T. B.</given-names></name><name><surname>Salas-Magana</surname><given-names>M.</given-names></name><name><surname>Juarez-Rojop</surname><given-names>I. E.</given-names></name><name><surname>Lopez-Narvaez</surname><given-names>M. L.</given-names></name><name><surname>Tovilla-Zarate</surname><given-names>C. A.</given-names></name><name><surname>Hernandez-Diaz</surname><given-names>Y.</given-names></name></person-group> (<year>2017</year>). <article-title>Exploring the association between BDNF Val66Met polymorphism and suicidal behavior: meta-analysis and systematic review.</article-title>
<volume>94</volume>
<fpage>208</fpage>–<lpage>217</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpsychires.2017.07.020</pub-id>
<pub-id pub-id-type="pmid">28756290</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Govindarajan</surname><given-names>A.</given-names></name><name><surname>Rao</surname><given-names>B. S.</given-names></name><name><surname>Nair</surname><given-names>D.</given-names></name><name><surname>Trinh</surname><given-names>M.</given-names></name><name><surname>Mawjee</surname><given-names>N.</given-names></name><name><surname>Tonegawa</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Transgenic brain-derived neurotrophic factor expression causes both anxiogenic and antidepressant effects.</article-title>
<volume>103</volume>
<fpage>13208</fpage>–<lpage>13213</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0605180103</pub-id>
<pub-id pub-id-type="pmid">16924103</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gratacos</surname><given-names>M.</given-names></name><name><surname>Gonzalez</surname><given-names>J. R.</given-names></name><name><surname>Mercader</surname><given-names>J. M.</given-names></name><name><surname>De Cid</surname><given-names>R.</given-names></name><name><surname>Urretavizcaya</surname><given-names>M.</given-names></name><name><surname>Estivill</surname><given-names>X.</given-names></name></person-group> (<year>2007</year>). <article-title>Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia.</article-title>
<volume>61</volume>
<fpage>911</fpage>–<lpage>922</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2006.08.025</pub-id>
<pub-id pub-id-type="pmid">17217930</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gyekis</surname><given-names>J. P.</given-names></name><name><surname>Yu</surname><given-names>W.</given-names></name><name><surname>Dong</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Qian</surname><given-names>J.</given-names></name><name><surname>Kota</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>No association of genetic variants in BDNF with major depression: a meta- and gene-based analysis.</article-title>
<volume>162B</volume>
<fpage>61</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.b.32122</pub-id>
<pub-id pub-id-type="pmid">23184535</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haerian</surname><given-names>B. S.</given-names></name></person-group> (<year>2013</year>). <article-title>BDNF rs6265 polymorphism and drug addiction: a systematic review and meta-analysis.</article-title>
<volume>14</volume>
<fpage>2055</fpage>–<lpage>2065</lpage>. <pub-id pub-id-type="doi">10.2217/pgs.13.217</pub-id>
<pub-id pub-id-type="pmid">24279859</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hajek</surname><given-names>T.</given-names></name><name><surname>Kopecek</surname><given-names>M.</given-names></name><name><surname>Hoschl</surname><given-names>C.</given-names></name></person-group> (<year>2012</year>). <article-title>Reduced hippocampal volumes in healthy carriers of brain-derived neurotrophic factor Val66Met polymorphism: meta-analysis.</article-title>
<volume>13</volume>
<fpage>178</fpage>–<lpage>187</lpage>. <pub-id pub-id-type="doi">10.3109/15622975.2011.580005</pub-id>
<pub-id pub-id-type="pmid">21722019</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harrisberger</surname><given-names>F.</given-names></name><name><surname>Smieskova</surname><given-names>R.</given-names></name><name><surname>Schmidt</surname><given-names>A.</given-names></name><name><surname>Lenz</surname><given-names>C.</given-names></name><name><surname>Walter</surname><given-names>A.</given-names></name><name><surname>Wittfeld</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>BDNF Val66Met polymorphism and hippocampal volume in neuropsychiatric disorders: a systematic review and meta-analysis.</article-title>
<volume>55</volume>
<fpage>107</fpage>–<lpage>118</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2015.04.017</pub-id>
<pub-id pub-id-type="pmid">25956254</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harrisberger</surname><given-names>F.</given-names></name><name><surname>Spalek</surname><given-names>K.</given-names></name><name><surname>Smieskova</surname><given-names>R.</given-names></name><name><surname>Schmidt</surname><given-names>A.</given-names></name><name><surname>Coynel</surname><given-names>D.</given-names></name><name><surname>Milnik</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>The association of the BDNF Val66Met polymorphism and the hippocampal volumes in healthy humans: a joint meta-analysis of published and new data.</article-title>
<volume>42</volume>
<fpage>267</fpage>–<lpage>278</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2014.03.011</pub-id>
<pub-id pub-id-type="pmid">24674929</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harte-Hargrove</surname><given-names>L. C.</given-names></name><name><surname>Maclusky</surname><given-names>N. J.</given-names></name><name><surname>Scharfman</surname><given-names>H. E.</given-names></name></person-group> (<year>2013</year>). <article-title>Brain-derived neurotrophic factor-estrogen interactions in the hippocampal mossy fiber pathway: implications for normal brain function and disease.</article-title>
<volume>239</volume>
<fpage>46</fpage>–<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2012.12.029</pub-id>
<pub-id pub-id-type="pmid">23276673</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayley</surname><given-names>S.</given-names></name><name><surname>Du</surname><given-names>L.</given-names></name><name><surname>Litteljohn</surname><given-names>D.</given-names></name><name><surname>Palkovits</surname><given-names>M.</given-names></name><name><surname>Faludi</surname><given-names>G.</given-names></name><name><surname>Merali</surname><given-names>Z.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Gender and brain regions specific differences in brain derived neurotrophic factor protein levels of depressed individuals who died through suicide.</article-title>
<volume>600</volume>
<fpage>12</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2015.05.052</pub-id>
<pub-id pub-id-type="pmid">26033186</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>R. A.</given-names></name><name><surname>Wu</surname><given-names>Y. W.</given-names></name><name><surname>Kwek</surname><given-names>P.</given-names></name><name><surname>Van Den Buuse</surname><given-names>M.</given-names></name></person-group> (<year>2012</year>). <article-title>Modulatory effects of sex steroid hormones on brain-derived neurotrophic factor-tyrosine kinase B expression during adolescent development in C57Bl/6 mice.</article-title>
<volume>24</volume>
<fpage>774</fpage>–<lpage>788</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2826.2012.02277.x</pub-id>
<pub-id pub-id-type="pmid">22221196</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hofer</surname><given-names>M.</given-names></name><name><surname>Pagliusi</surname><given-names>S. R.</given-names></name><name><surname>Hohn</surname><given-names>A.</given-names></name><name><surname>Leibrock</surname><given-names>J.</given-names></name><name><surname>Barde</surname><given-names>Y. A.</given-names></name></person-group> (<year>1990</year>). <article-title>Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain.</article-title>
<volume>9</volume>
<fpage>2459</fpage>–<lpage>2464</lpage>.</mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>C. J.</given-names></name><name><surname>Huo</surname><given-names>S. J.</given-names></name><name><surname>Yen</surname><given-names>F. C.</given-names></name><name><surname>Tung</surname><given-names>C. L.</given-names></name><name><surname>Pan</surname><given-names>G. M.</given-names></name><name><surname>Tsai</surname><given-names>S. J.</given-names></name></person-group> (<year>2003a</year>). <article-title>Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior.</article-title>
<volume>48</volume>
<fpage>186</fpage>–<lpage>189</lpage>. <pub-id pub-id-type="doi">10.1159/000074636</pub-id>
<pub-id pub-id-type="pmid">14673216</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>C. J.</given-names></name><name><surname>Liou</surname><given-names>Y. J.</given-names></name><name><surname>Tsai</surname><given-names>S. J.</given-names></name></person-group> (<year>2011</year>). <article-title>Effects of BDNF polymorphisms on brain function and behavior in health and disease.</article-title>
<volume>86</volume>
<fpage>287</fpage>–<lpage>297</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainresbull.2011.08.019</pub-id>
<pub-id pub-id-type="pmid">21924328</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>C. J.</given-names></name><name><surname>Liu</surname><given-names>H. C.</given-names></name><name><surname>Liu</surname><given-names>T. Y.</given-names></name><name><surname>Lin</surname><given-names>C. H.</given-names></name><name><surname>Cheng</surname><given-names>C. Y.</given-names></name><name><surname>Tsai</surname><given-names>S. J.</given-names></name></person-group> (<year>2003b</year>). <article-title>Brain-derived neurotrophic factor (BDNF) Val66Met polymorphisms in Parkinson’s disease and age of onset.</article-title>
<volume>353</volume>
<fpage>75</fpage>–<lpage>77</lpage>.</mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hosang</surname><given-names>G. M.</given-names></name><name><surname>Shiles</surname><given-names>C.</given-names></name><name><surname>Tansey</surname><given-names>K. E.</given-names></name><name><surname>Mcguffin</surname><given-names>P.</given-names></name><name><surname>Uher</surname><given-names>R.</given-names></name></person-group> (<year>2014</year>). <article-title>Interaction between stress and the BDNF Val66Met polymorphism in depression: a systematic review and meta-analysis.</article-title>
<volume>12</volume>:<issue>7</issue>. <pub-id pub-id-type="doi">10.1186/1741-7015-12-7</pub-id>
<pub-id pub-id-type="pmid">24433458</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>C. C.</given-names></name><name><surname>Liu</surname><given-names>M. E.</given-names></name><name><surname>Chou</surname><given-names>K. H.</given-names></name><name><surname>Yang</surname><given-names>A. C.</given-names></name><name><surname>Hung</surname><given-names>C. C.</given-names></name><name><surname>Hong</surname><given-names>C. J.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Effect of BDNF Val66Met polymorphism on regional white matter hyperintensities and cognitive function in elderly males without dementia.</article-title>
<volume>39</volume>
<fpage>94</fpage>–<lpage>103</lpage>. <pub-id pub-id-type="doi">10.1016/j.psyneuen.2013.09.027</pub-id>
<pub-id pub-id-type="pmid">24275008</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hwang</surname><given-names>J. P.</given-names></name><name><surname>Tsai</surname><given-names>S. J.</given-names></name><name><surname>Hong</surname><given-names>C. J.</given-names></name><name><surname>Yang</surname><given-names>C. H.</given-names></name><name><surname>Lirng</surname><given-names>J. F.</given-names></name><name><surname>Yang</surname><given-names>Y. M.</given-names></name></person-group> (<year>2006</year>). <article-title>The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression.</article-title>
<volume>27</volume>
<fpage>1834</fpage>–<lpage>1837</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2005.10.013</pub-id>
<pub-id pub-id-type="pmid">16343697</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ilchibaeva</surname><given-names>T. V.</given-names></name><name><surname>Tsybko</surname><given-names>A. S.</given-names></name><name><surname>Kozhemyakina</surname><given-names>R. V.</given-names></name><name><surname>Kondaurova</surname><given-names>E. M.</given-names></name><name><surname>Popova</surname><given-names>N. K.</given-names></name><name><surname>Naumenko</surname><given-names>V. S.</given-names></name></person-group> (<year>2018</year>). <article-title>Genetically defined fear-induced aggression: focus on BDNF and its receptors.</article-title>
<volume>343</volume>
<fpage>102</fpage>–<lpage>110</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2018.01.034</pub-id>
<pub-id pub-id-type="pmid">29425916</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>H.</given-names></name><name><surname>Dai</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Jiang</surname><given-names>D.</given-names></name><name><surname>Zhou</surname><given-names>X.</given-names></name><name><surname>Lin</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Association of BDNF and BCHE with Alzheimer’s disease: meta-analysis based on 56 genetic case-control studies of 12,563 cases and 12,622 controls.</article-title>
<volume>9</volume>
<fpage>1831</fpage>–<lpage>1840</lpage>. <pub-id pub-id-type="doi">10.3892/etm.2015.2327</pub-id>
<pub-id pub-id-type="pmid">26136901</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>R.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>Z. Y.</given-names></name></person-group> (<year>2009</year>). <article-title>BDNF Val66Met polymorphism is associated with unstable angina.</article-title>
<volume>400</volume>
<fpage>3</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.cca.2008.10.017</pub-id>
<pub-id pub-id-type="pmid">19013140</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>R.</given-names></name><name><surname>Babyak</surname><given-names>M. A.</given-names></name><name><surname>Brummett</surname><given-names>B. H.</given-names></name><name><surname>Siegler</surname><given-names>I. C.</given-names></name><name><surname>Kuhn</surname><given-names>C. M.</given-names></name><name><surname>Williams</surname><given-names>R. B.</given-names></name></person-group> (<year>2017</year>). <article-title>Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism interacts with gender to influence cortisol responses to mental stress.</article-title>
<volume>79</volume>
<fpage>13</fpage>–<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1016/j.psyneuen.2017.02.005</pub-id>
<pub-id pub-id-type="pmid">28249185</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>P.</given-names></name><name><surname>Andiappan</surname><given-names>A. K.</given-names></name><name><surname>Quek</surname><given-names>J. M.</given-names></name><name><surname>Lee</surname><given-names>B.</given-names></name><name><surname>Au</surname><given-names>B.</given-names></name><name><surname>Sio</surname><given-names>Y. Y.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>A functional brain-derived neurotrophic factor (BDNF) gene variant increases the risk of moderate-to-severe allergic rhinitis.</article-title>
<volume>135</volume>
<fpage>1486.e8</fpage>–<lpage>1493.e8</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2014.12.1870</pub-id>
<pub-id pub-id-type="pmid">25649076</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joyce</surname><given-names>J. N.</given-names></name><name><surname>Ryoo</surname><given-names>H. L.</given-names></name><name><surname>Beach</surname><given-names>T. B.</given-names></name><name><surname>Caviness</surname><given-names>J. N.</given-names></name><name><surname>Stacy</surname><given-names>M.</given-names></name><name><surname>Gurevich</surname><given-names>E. V.</given-names></name><etal></etal></person-group> (<year>2002</year>). <article-title>Loss of response to levodopa in Parkinson’s disease and co-occurrence with dementia: role of D3 and not D2 receptors.</article-title>
<volume>955</volume>
<fpage>138</fpage>–<lpage>152</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-8993(02)03396-6</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaess</surname><given-names>B. M.</given-names></name><name><surname>Preis</surname><given-names>S. R.</given-names></name><name><surname>Lieb</surname><given-names>W.</given-names></name><name><surname>Beiser</surname><given-names>A. S.</given-names></name><name><surname>Yang</surname><given-names>Q.</given-names></name><name><surname>Chen</surname><given-names>T. C.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Circulating brain-derived neurotrophic factor concentrations and the risk of cardiovascular disease in the community.</article-title>
<volume>4</volume>:<issue>e001544</issue>. <pub-id pub-id-type="doi">10.1161/JAHA.114.001544</pub-id>
<pub-id pub-id-type="pmid">25762803</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kambeitz</surname><given-names>J. P.</given-names></name><name><surname>Bhattacharyya</surname><given-names>S.</given-names></name><name><surname>Kambeitz-Ilankovic</surname><given-names>L. M.</given-names></name><name><surname>Valli</surname><given-names>I.</given-names></name><name><surname>Collier</surname><given-names>D. A.</given-names></name><name><surname>Mcguire</surname><given-names>P.</given-names></name></person-group> (<year>2012</year>). <article-title>Effect of BDNF val(66)met polymorphism on declarative memory and its neural substrate: a meta-analysis.</article-title>
<volume>36</volume>
<fpage>2165</fpage>–<lpage>2177</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2012.07.002</pub-id>
<pub-id pub-id-type="pmid">22813992</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanazawa</surname><given-names>T.</given-names></name><name><surname>Glatt</surname><given-names>S. J.</given-names></name><name><surname>Kia-Keating</surname><given-names>B.</given-names></name><name><surname>Yoneda</surname><given-names>H.</given-names></name><name><surname>Tsuang</surname><given-names>M. T.</given-names></name></person-group> (<year>2007</year>). <article-title>Meta-analysis reveals no association of the Val66Met polymorphism of brain-derived neurotrophic factor with either schizophrenia or bipolar disorder.</article-title>
<volume>17</volume>
<fpage>165</fpage>–<lpage>170</lpage>. <pub-id pub-id-type="doi">10.1097/YPG.0b013e32801da2e2</pub-id>
<pub-id pub-id-type="pmid">17417060</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katoh-Semba</surname><given-names>R.</given-names></name><name><surname>Wakako</surname><given-names>R.</given-names></name><name><surname>Komori</surname><given-names>T.</given-names></name><name><surname>Shigemi</surname><given-names>H.</given-names></name><name><surname>Miyazaki</surname><given-names>N.</given-names></name><name><surname>Ito</surname><given-names>H.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Age-related changes in BDNF protein levels in human serum: differences between autism cases and normal controls.</article-title>
<volume>25</volume>
<fpage>367</fpage>–<lpage>372</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijdevneu.2007.07.002</pub-id>
<pub-id pub-id-type="pmid">17804189</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawashima</surname><given-names>K.</given-names></name><name><surname>Ikeda</surname><given-names>M.</given-names></name><name><surname>Kishi</surname><given-names>T.</given-names></name><name><surname>Kitajima</surname><given-names>T.</given-names></name><name><surname>Yamanouchi</surname><given-names>Y.</given-names></name><name><surname>Kinoshita</surname><given-names>Y.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>BDNF is not associated with schizophrenia: data from a Japanese population study and meta-analysis.</article-title>
<volume>112</volume>
<fpage>72</fpage>–<lpage>79</lpage>. <pub-id pub-id-type="doi">10.1016/j.schres.2009.03.040</pub-id>
<pub-id pub-id-type="pmid">19406621</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keverne</surname><given-names>E. B.</given-names></name></person-group> (<year>2014</year>). <article-title>Significance of epigenetics for understanding brain development, brain evolution and behaviour.</article-title>
<volume>264</volume>
<fpage>207</fpage>–<lpage>217</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2012.11.030</pub-id>
<pub-id pub-id-type="pmid">23201253</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kheirollahi</surname><given-names>M.</given-names></name><name><surname>Kazemi</surname><given-names>E.</given-names></name><name><surname>Ashouri</surname><given-names>S.</given-names></name></person-group> (<year>2016</year>). <article-title>Brain-derived neurotrophic factor gene Val66Met polymorphism and risk of schizophrenia: a meta-analysis of case-control studies.</article-title>
<volume>36</volume>
<fpage>1</fpage>–<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1007/s10571-015-0229-z</pub-id>
<pub-id pub-id-type="pmid">26134309</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S. W.</given-names></name><name><surname>Lee</surname><given-names>J. Y.</given-names></name><name><surname>Kang</surname><given-names>H. J.</given-names></name><name><surname>Kim</surname><given-names>S. Y.</given-names></name><name><surname>Bae</surname><given-names>K. Y.</given-names></name><name><surname>Kim</surname><given-names>J. M.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Gender-specific associations of the brain-derived neurotrophic factor Val66Met polymorphism with neurocognitive and clinical features in schizophrenia.</article-title>
<volume>14</volume>
<fpage>270</fpage>–<lpage>278</lpage>. <pub-id pub-id-type="doi">10.9758/cpn.2016.14.3.270</pub-id>
<pub-id pub-id-type="pmid">27489381</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krebs</surname><given-names>M. O.</given-names></name><name><surname>Guillin</surname><given-names>O.</given-names></name><name><surname>Bourdell</surname><given-names>M. C.</given-names></name><name><surname>Schwartz</surname><given-names>J. C.</given-names></name><name><surname>Olie</surname><given-names>J. P.</given-names></name><name><surname>Poirier</surname><given-names>M. F.</given-names></name><etal></etal></person-group> (<year>2000</year>). <article-title>Brain derived neurotrophic factor (BDNF) gene variants association with age at onset and therapeutic response in schizophrenia.</article-title>
<volume>5</volume>
<fpage>558</fpage>–<lpage>562</lpage>. <pub-id pub-id-type="doi">10.1038/sj.mp.4000749</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kunugi</surname><given-names>H.</given-names></name><name><surname>Ueki</surname><given-names>A.</given-names></name><name><surname>Otsuka</surname><given-names>M.</given-names></name><name><surname>Isse</surname><given-names>K.</given-names></name><name><surname>Hirasawa</surname><given-names>H.</given-names></name><name><surname>Kato</surname><given-names>N.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated with late-onset Alzheimer’s disease.</article-title>
<volume>6</volume>
<fpage>83</fpage>–<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1038/sj.mp.4000792</pub-id>
<pub-id pub-id-type="pmid">11244490</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laing</surname><given-names>K. R.</given-names></name><name><surname>Mitchell</surname><given-names>D.</given-names></name><name><surname>Wersching</surname><given-names>H.</given-names></name><name><surname>Czira</surname><given-names>M. E.</given-names></name><name><surname>Berger</surname><given-names>K.</given-names></name><name><surname>Baune</surname><given-names>B. T.</given-names></name></person-group> (<year>2012</year>). <article-title>Brain-derived neurotrophic factor (BDNF) gene: a gender-specific role in cognitive function during normal cognitive aging of the MEMO-Study?</article-title>
<volume>34</volume>
<fpage>1011</fpage>–<lpage>1022</lpage>. <pub-id pub-id-type="doi">10.1007/s11357-011-9275-8</pub-id>
<pub-id pub-id-type="pmid">21695421</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lam</surname><given-names>P.</given-names></name><name><surname>Cheng</surname><given-names>C. Y.</given-names></name><name><surname>Hong</surname><given-names>C. J.</given-names></name><name><surname>Tsai</surname><given-names>S. J.</given-names></name></person-group> (<year>2004</year>). <article-title>Association study of a brain-derived neurotrophic factor (Val66Met) genetic polymorphism and panic disorder.</article-title>
<volume>49</volume>
<fpage>178</fpage>–<lpage>181</lpage>. <pub-id pub-id-type="doi">10.1159/000077362</pub-id>
<pub-id pub-id-type="pmid">15118353</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>Y. H.</given-names></name><name><surname>Song</surname><given-names>G. G.</given-names></name></person-group> (<year>2014</year>). <article-title>BDNF 196 G/A and 270 C/T polymorphisms and susceptibility to Parkinson’s disease: a meta-analysis.</article-title>
<volume>46</volume>
<fpage>59</fpage>–<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1080/00222895.2013.862199</pub-id>
<pub-id pub-id-type="pmid">24329127</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Chang</surname><given-names>H.</given-names></name><name><surname>Xiao</surname><given-names>X.</given-names></name></person-group> (<year>2016</year>). <article-title>BDNF Val66Met polymorphism and bipolar disorder in European populations: a risk association in case-control, family-based and GWAS studies.</article-title>
<volume>68</volume>
<fpage>218</fpage>–<lpage>233</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2016.05.031</pub-id>
<pub-id pub-id-type="pmid">27236043</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>M.</given-names></name><name><surname>Masugi-Tokita</surname><given-names>M.</given-names></name><name><surname>Takanami</surname><given-names>K.</given-names></name><name><surname>Yamada</surname><given-names>S.</given-names></name><name><surname>Kawata</surname><given-names>M.</given-names></name></person-group> (<year>2012</year>). <article-title>Testosterone has sublayer-specific effects on dendritic spine maturation mediated by BDNF and PSD-95 in pyramidal neurons in the hippocampus CA1 area.</article-title>
<volume>1484</volume>
<fpage>76</fpage>–<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2012.09.028</pub-id>
<pub-id pub-id-type="pmid">23010313</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Licinio</surname><given-names>J.</given-names></name><name><surname>Dong</surname><given-names>C.</given-names></name><name><surname>Wong</surname><given-names>M. L.</given-names></name></person-group> (<year>2009</year>). <article-title>Novel sequence variations in the brain-derived neurotrophic factor gene and association with major depression and antidepressant treatment response.</article-title>
<volume>66</volume>
<fpage>488</fpage>–<lpage>497</lpage>. <pub-id pub-id-type="doi">10.1001/archgenpsychiatry.2009.38</pub-id>
<pub-id pub-id-type="pmid">19414708</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>E.</given-names></name><name><surname>Hong</surname><given-names>C. J.</given-names></name><name><surname>Hwang</surname><given-names>J. P.</given-names></name><name><surname>Liou</surname><given-names>Y. J.</given-names></name><name><surname>Yang</surname><given-names>C. H.</given-names></name><name><surname>Cheng</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>Gene-gene interactions of the brain-derived neurotrophic-factor and neurotrophic tyrosine kinase receptor 2 genes in geriatric depression.</article-title>
<volume>12</volume>
<fpage>387</fpage>–<lpage>393</lpage>. <pub-id pub-id-type="doi">10.1089/rej.2009.0871</pub-id>
<pub-id pub-id-type="pmid">20014955</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>E.</given-names></name><name><surname>Kuo</surname><given-names>P. H.</given-names></name><name><surname>Liu</surname><given-names>Y. L.</given-names></name><name><surname>Yang</surname><given-names>A. C.</given-names></name><name><surname>Kao</surname><given-names>C. F.</given-names></name><name><surname>Tsai</surname><given-names>S. J.</given-names></name></person-group> (<year>2017</year>). <article-title>Effects of circadian clock genes and environmental factors on cognitive aging in old adults in a Taiwanese population.</article-title>
<volume>8</volume>
<fpage>24088</fpage>–<lpage>24098</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.15493</pub-id>
<pub-id pub-id-type="pmid">28412756</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>P. H.</given-names></name><name><surname>Tsai</surname><given-names>S. J.</given-names></name><name><surname>Huang</surname><given-names>C. W.</given-names></name><name><surname>Mu-En</surname><given-names>L.</given-names></name><name><surname>Hsu</surname><given-names>S. W.</given-names></name><name><surname>Lee</surname><given-names>C. C.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>Dose-dependent genotype effects of BDNF Val66Met polymorphism on default mode network in early stage Alzheimer’s disease.</article-title>
<volume>7</volume>
<fpage>54200</fpage>–<lpage>54214</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.11027</pub-id>
<pub-id pub-id-type="pmid">27494844</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>Y.</given-names></name><name><surname>Cheng</surname><given-names>S.</given-names></name><name><surname>Xie</surname><given-names>Z.</given-names></name><name><surname>Zhang</surname><given-names>D.</given-names></name></person-group> (<year>2014</year>). <article-title>Association of rs6265 and rs2030324 polymorphisms in brain-derived neurotrophic factor gene with Alzheimer’s disease: a meta-analysis.</article-title>
<volume>9</volume>:<issue>e94961</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0094961</pub-id>
<pub-id pub-id-type="pmid">24733169</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>M. E.</given-names></name><name><surname>Huang</surname><given-names>C. C.</given-names></name><name><surname>Chen</surname><given-names>M. H.</given-names></name><name><surname>Yang</surname><given-names>A. C.</given-names></name><name><surname>Tu</surname><given-names>P. C.</given-names></name><name><surname>Yeh</surname><given-names>H. L.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Effect of the BDNF Val66Met polymorphism on regional gray matter volumes and cognitive function in the Chinese population.</article-title>
<volume>16</volume>
<fpage>127</fpage>–<lpage>136</lpage>. <pub-id pub-id-type="doi">10.1007/s12017-013-8265-7</pub-id>
<pub-id pub-id-type="pmid">24366608</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Q. R.</given-names></name><name><surname>Walther</surname><given-names>D.</given-names></name><name><surname>Drgon</surname><given-names>T.</given-names></name><name><surname>Polesskaya</surname><given-names>O.</given-names></name><name><surname>Lesnick</surname><given-names>T. G.</given-names></name><name><surname>Strain</surname><given-names>K. J.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Human brain derived neurotrophic factor (BDNF) genes, splicing patterns, and assessments of associations with substance abuse and Parkinson’s disease.</article-title>
<volume>134B</volume>
<fpage>93</fpage>–<lpage>103</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.b.30109</pub-id>
<pub-id pub-id-type="pmid">15666411</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lommatzsch</surname><given-names>M.</given-names></name><name><surname>Zingler</surname><given-names>D.</given-names></name><name><surname>Schuhbaeck</surname><given-names>K.</given-names></name><name><surname>Schloetcke</surname><given-names>K.</given-names></name><name><surname>Zingler</surname><given-names>C.</given-names></name><name><surname>Schuff-Werner</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>The impact of age, weight and gender on BDNF levels in human platelets and plasma.</article-title>
<volume>26</volume>
<fpage>115</fpage>–<lpage>123</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2004.03.002</pub-id>
<pub-id pub-id-type="pmid">15585351</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>B.</given-names></name><name><surname>Pang</surname><given-names>P. T.</given-names></name><name><surname>Woo</surname><given-names>N. H.</given-names></name></person-group> (<year>2005</year>). <article-title>The yin and yang of neurotrophin action.</article-title>
<volume>6</volume>
<fpage>603</fpage>–<lpage>614</lpage>. <pub-id pub-id-type="doi">10.1038/nrn1726</pub-id>
<pub-id pub-id-type="pmid">16062169</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luine</surname><given-names>V.</given-names></name><name><surname>Frankfurt</surname><given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>Interactions between estradiol, BDNF and dendritic spines in promoting memory.</article-title>
<volume>239</volume>
<fpage>34</fpage>–<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2012.10.019</pub-id>
<pub-id pub-id-type="pmid">23079626</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mandelman</surname><given-names>S. D.</given-names></name><name><surname>Grigorenko</surname><given-names>E. L.</given-names></name></person-group> (<year>2012</year>). <article-title>BDNF Val66Met and cognition: all, none, or some? A meta-analysis of the genetic association.</article-title>
<volume>11</volume>
<fpage>127</fpage>–<lpage>136</lpage>. <pub-id pub-id-type="doi">10.1111/j.1601-183X.2011.00738.x</pub-id>
<pub-id pub-id-type="pmid">21980924</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mariani</surname><given-names>S.</given-names></name><name><surname>Ventriglia</surname><given-names>M.</given-names></name><name><surname>Simonelli</surname><given-names>I.</given-names></name><name><surname>Bucossi</surname><given-names>S.</given-names></name><name><surname>Siotto</surname><given-names>M.</given-names></name><name><surname>R</surname><given-names>R. S.</given-names></name></person-group> (<year>2015</year>). <article-title>Meta-analysis study on the role of bone-derived neurotrophic factor Val66Met polymorphism in Parkinson’s disease.</article-title>
<volume>18</volume>
<fpage>40</fpage>–<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1089/rej.2014.1612</pub-id>
<pub-id pub-id-type="pmid">25431370</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McEwen</surname><given-names>B. S.</given-names></name><name><surname>Bowles</surname><given-names>N. P.</given-names></name><name><surname>Gray</surname><given-names>J. D.</given-names></name><name><surname>Hill</surname><given-names>M. N.</given-names></name><name><surname>Hunter</surname><given-names>R. G.</given-names></name><name><surname>Karatsoreos</surname><given-names>I. N.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Mechanisms of stress in the brain.</article-title>
<volume>18</volume>
<fpage>1353</fpage>–<lpage>1363</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4086</pub-id>
<pub-id pub-id-type="pmid">26404710</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Misiak</surname><given-names>B.</given-names></name><name><surname>Stramecki</surname><given-names>F.</given-names></name><name><surname>Gaweda</surname><given-names>L.</given-names></name><name><surname>Prochwicz</surname><given-names>K.</given-names></name><name><surname>Sasiadek</surname><given-names>M. M.</given-names></name><name><surname>Moustafa</surname><given-names>A. A.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Interactions between variation in candidate genes and environmental factors in the etiology of schizophrenia and bipolar disorder: a systematic review.</article-title>
<pub-id pub-id-type="doi">10.1007/s12035-017-0708-y</pub-id>
<comment>[Epub ahead of print]</comment>. <pub-id pub-id-type="pmid">28822116</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miura</surname><given-names>I.</given-names></name><name><surname>Zhang</surname><given-names>J. P.</given-names></name><name><surname>Nitta</surname><given-names>M.</given-names></name><name><surname>Lencz</surname><given-names>T.</given-names></name><name><surname>Kane</surname><given-names>J. M.</given-names></name><name><surname>Malhotra</surname><given-names>A. K.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>BDNF Val66Met polymorphism and antipsychotic-induced tardive dyskinesia occurrence and severity: a meta-analysis.</article-title>
<volume>152</volume>
<fpage>365</fpage>–<lpage>372</lpage>. <pub-id pub-id-type="doi">10.1016/j.schres.2013.12.011</pub-id>
<pub-id pub-id-type="pmid">24411528</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizui</surname><given-names>T.</given-names></name><name><surname>Ishikawa</surname><given-names>Y.</given-names></name><name><surname>Kumanogoh</surname><given-names>H.</given-names></name><name><surname>Lume</surname><given-names>M.</given-names></name><name><surname>Matsumoto</surname><given-names>T.</given-names></name><name><surname>Hara</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>BDNF pro-peptide actions facilitate hippocampal LTD and are altered by the common BDNF polymorphism Val66Met.</article-title>
<volume>112</volume>
<fpage>E3067</fpage>–<lpage>E3074</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1422336112</pub-id>
<pub-id pub-id-type="pmid">26015580</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Momose</surname><given-names>Y.</given-names></name><name><surname>Murata</surname><given-names>M.</given-names></name><name><surname>Kobayashi</surname><given-names>K.</given-names></name><name><surname>Tachikawa</surname><given-names>M.</given-names></name><name><surname>Nakabayashi</surname><given-names>Y.</given-names></name><name><surname>Kanazawa</surname><given-names>I.</given-names></name><etal></etal></person-group> (<year>2002</year>). <article-title>Association studies of multiple candidate genes for Parkinson’s disease using single nucleotide polymorphisms.</article-title>
<volume>51</volume>
<fpage>133</fpage>–<lpage>136</lpage>. <pub-id pub-id-type="doi">10.1002/ana.10079</pub-id>
<pub-id pub-id-type="pmid">11782995</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>D. D.</given-names></name><name><surname>Cole</surname><given-names>N. B.</given-names></name><name><surname>Segal</surname><given-names>M.</given-names></name></person-group> (<year>1998</year>). <article-title>Brain-derived neurotrophic factor mediates estradiol-induced dendritic spine formation in hippocampal neurons.</article-title>
<volume>95</volume>
<fpage>11412</fpage>–<lpage>11417</lpage>. <pub-id pub-id-type="pmid">9736750</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakata</surname><given-names>K.</given-names></name><name><surname>Ujike</surname><given-names>H.</given-names></name><name><surname>Sakai</surname><given-names>A.</given-names></name><name><surname>Uchida</surname><given-names>N.</given-names></name><name><surname>Nomura</surname><given-names>A.</given-names></name><name><surname>Imamura</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Association study of the brain-derived neurotrophic factor (BDNF) gene with bipolar disorder.</article-title>
<volume>337</volume>
<fpage>17</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/S0304-3940(02)01292-2</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naoe</surname><given-names>Y.</given-names></name><name><surname>Shinkai</surname><given-names>T.</given-names></name><name><surname>Hori</surname><given-names>H.</given-names></name><name><surname>Fukunaka</surname><given-names>Y.</given-names></name><name><surname>Utsunomiya</surname><given-names>K.</given-names></name><name><surname>Sakata</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>No association between the brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and schizophrenia in Asian populations: evidence from a case-control study and meta-analysis.</article-title>
<volume>415</volume>
<fpage>108</fpage>–<lpage>112</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2007.01.006</pub-id>
<pub-id pub-id-type="pmid">17267117</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neves-Pereira</surname><given-names>M.</given-names></name><name><surname>Mundo</surname><given-names>E.</given-names></name><name><surname>Muglia</surname><given-names>P.</given-names></name><name><surname>King</surname><given-names>N.</given-names></name><name><surname>Macciardi</surname><given-names>F.</given-names></name><name><surname>Kennedy</surname><given-names>J. L.</given-names></name></person-group> (<year>2002</year>). <article-title>The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study.</article-title>
<volume>71</volume>
<fpage>651</fpage>–<lpage>655</lpage>. <pub-id pub-id-type="doi">10.1086/342288</pub-id>
<pub-id pub-id-type="pmid">12161822</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Notaras</surname><given-names>M.</given-names></name><name><surname>Du</surname><given-names>X.</given-names></name><name><surname>Gogos</surname><given-names>J.</given-names></name><name><surname>Van Den Buuse</surname><given-names>M.</given-names></name><name><surname>Hill</surname><given-names>R. A.</given-names></name></person-group> (<year>2017</year>). <article-title>The BDNF Val66Met polymorphism regulates glucocorticoid-induced corticohippocampal remodeling and behavioral despair.</article-title>
<volume>7</volume>:<issue>e1233</issue>. <pub-id pub-id-type="doi">10.1038/tp.2017.205</pub-id>
<pub-id pub-id-type="pmid">28926000</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Notaras</surname><given-names>M.</given-names></name><name><surname>Hill</surname><given-names>R.</given-names></name><name><surname>Van Den Buuse</surname><given-names>M.</given-names></name></person-group> (<year>2015a</year>). <article-title>A role for the BDNF gene Val66Met polymorphism in schizophrenia? A comprehensive review.</article-title>
<volume>51</volume>
<fpage>15</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1016/j.neubiorev.2014.12.016</pub-id>
<pub-id pub-id-type="pmid">25562189</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Notaras</surname><given-names>M.</given-names></name><name><surname>Hill</surname><given-names>R.</given-names></name><name><surname>Van Den Buuse</surname><given-names>M.</given-names></name></person-group> (<year>2015b</year>). <article-title>The BDNF gene Val66Met polymorphism as a modifier of psychiatric disorder susceptibility: progress and controversy.</article-title>
<volume>20</volume>
<fpage>916</fpage>–<lpage>930</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2015.27</pub-id>
<pub-id pub-id-type="pmid">25824305</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ottem</surname><given-names>E. N.</given-names></name><name><surname>Bailey</surname><given-names>D. J.</given-names></name><name><surname>Jordan</surname><given-names>C. L.</given-names></name><name><surname>Breedlove</surname><given-names>S. M.</given-names></name></person-group> (<year>2013</year>). <article-title>With a little help from my friends: androgens tap BDNF signaling pathways to alter neural circuits.</article-title>
<volume>239</volume>
<fpage>124</fpage>–<lpage>138</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2012.12.019</pub-id>
<pub-id pub-id-type="pmid">23262234</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pang</surname><given-names>P. T.</given-names></name><name><surname>Teng</surname><given-names>H. K.</given-names></name><name><surname>Zaitsev</surname><given-names>E.</given-names></name><name><surname>Woo</surname><given-names>N. T.</given-names></name><name><surname>Sakata</surname><given-names>K.</given-names></name><name><surname>Zhen</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity.</article-title>
<volume>306</volume>
<fpage>487</fpage>–<lpage>491</lpage>. <pub-id pub-id-type="doi">10.1126/science.1100135</pub-id>
<pub-id pub-id-type="pmid">15486301</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papaleo</surname><given-names>F.</given-names></name><name><surname>Silverman</surname><given-names>J. L.</given-names></name><name><surname>Aney</surname><given-names>J.</given-names></name><name><surname>Tian</surname><given-names>Q.</given-names></name><name><surname>Barkan</surname><given-names>C. L.</given-names></name><name><surname>Chadman</surname><given-names>K. K.</given-names></name><etal></etal></person-group> (<year>2011</year>). <article-title>Working memory deficits, increased anxiety-like traits, and seizure susceptibility in BDNF overexpressing mice.</article-title>
<volume>18</volume>
<fpage>534</fpage>–<lpage>544</lpage>. <pub-id pub-id-type="doi">10.1101/lm.2213711</pub-id>
<pub-id pub-id-type="pmid">21791566</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pei</surname><given-names>Y.</given-names></name><name><surname>Smith</surname><given-names>A. K.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Pan</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>Q.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>The brain-derived neurotrophic-factor (BDNF) val66met polymorphism is associated with geriatric depression: a meta-analysis.</article-title>
<volume>159B</volume>
<fpage>560</fpage>–<lpage>566</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.b.32062</pub-id>
<pub-id pub-id-type="pmid">22610920</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petryshen</surname><given-names>T. L.</given-names></name><name><surname>Sabeti</surname><given-names>P. C.</given-names></name><name><surname>Aldinger</surname><given-names>K. A.</given-names></name><name><surname>Fry</surname><given-names>B.</given-names></name><name><surname>Fan</surname><given-names>J. B.</given-names></name><name><surname>Schaffner</surname><given-names>S. F.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Population genetic study of the brain-derived neurotrophic factor (BDNF) gene.</article-title>
<volume>15</volume>
<fpage>810</fpage>–<lpage>815</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2009.24</pub-id>
<pub-id pub-id-type="pmid">19255578</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pezawas</surname><given-names>L.</given-names></name><name><surname>Verchinski</surname><given-names>B. A.</given-names></name><name><surname>Mattay</surname><given-names>V. S.</given-names></name><name><surname>Callicott</surname><given-names>J. H.</given-names></name><name><surname>Kolachana</surname><given-names>B. S.</given-names></name><name><surname>Straub</surname><given-names>R. E.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology.</article-title>
<volume>24</volume>
<fpage>10099</fpage>–<lpage>10102</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2680-04.2004</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prats</surname><given-names>C.</given-names></name><name><surname>Arias</surname><given-names>B.</given-names></name><name><surname>Ortet</surname><given-names>G.</given-names></name><name><surname>Ibanez</surname><given-names>M. I.</given-names></name><name><surname>Moya</surname><given-names>J.</given-names></name><name><surname>Pomarol-Clotet</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Neurotrophins role in depressive symptoms and executive function performance: association analysis of NRN1 gene and its interaction with BDNF gene in a non-clinical sample.</article-title>
<volume>211</volume>
<fpage>92</fpage>–<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1016/j.jad.2016.11.017</pub-id>
<pub-id pub-id-type="pmid">28107668</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Proschel</surname><given-names>M.</given-names></name><name><surname>Saunders</surname><given-names>A.</given-names></name><name><surname>Roses</surname><given-names>A. D.</given-names></name><name><surname>Muller</surname><given-names>C. R.</given-names></name></person-group> (<year>1992</year>). <article-title>Dinucleotide repeat polymorphism at the human gene for the brain-derived neurotrophic factor (BDNF).</article-title>
<volume>1</volume>:<issue>353</issue>
<pub-id pub-id-type="doi">10.1093/hmg/1.5.353-a</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pruunsild</surname><given-names>P.</given-names></name><name><surname>Kazantseva</surname><given-names>A.</given-names></name><name><surname>Aid</surname><given-names>T.</given-names></name><name><surname>Palm</surname><given-names>K.</given-names></name><name><surname>Timmusk</surname><given-names>T.</given-names></name></person-group> (<year>2007</year>). <article-title>Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters.</article-title>
<volume>90</volume>
<fpage>397</fpage>–<lpage>406</lpage>. <pub-id pub-id-type="doi">10.1016/j.ygeno.2007.05.004</pub-id>
<pub-id pub-id-type="pmid">17629449</pub-id></mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>L.</given-names></name><name><surname>Zhao</surname><given-names>J.</given-names></name><name><surname>Shi</surname><given-names>Y.</given-names></name><name><surname>Zhao</surname><given-names>X.</given-names></name><name><surname>Feng</surname><given-names>G.</given-names></name><name><surname>Xu</surname><given-names>F.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Brain-derived neurotrophic factor and risk of schizophrenia: an association study and meta-analysis.</article-title>
<volume>353</volume>
<fpage>738</fpage>–<lpage>743</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2006.12.121</pub-id>
<pub-id pub-id-type="pmid">17196936</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rage</surname><given-names>F.</given-names></name><name><surname>Silhol</surname><given-names>M.</given-names></name><name><surname>Biname</surname><given-names>F.</given-names></name><name><surname>Arancibia</surname><given-names>S.</given-names></name><name><surname>Tapia-Arancibia</surname><given-names>L.</given-names></name></person-group> (<year>2007</year>). <article-title>Effect of aging on the expression of BDNF and TrkB isoforms in rat pituitary.</article-title>
<volume>28</volume>
<fpage>1088</fpage>–<lpage>1098</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2006.05.013</pub-id>
<pub-id pub-id-type="pmid">16769156</pub-id></mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ribeiro</surname><given-names>L.</given-names></name><name><surname>Busnello</surname><given-names>J. V.</given-names></name><name><surname>Cantor</surname><given-names>R. M.</given-names></name><name><surname>Whelan</surname><given-names>F.</given-names></name><name><surname>Whittaker</surname><given-names>P.</given-names></name><name><surname>Deloukas</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>The brain-derived neurotrophic factor rs6265 (Val66Met) polymorphism and depression in Mexican-Americans.</article-title>
<volume>18</volume>
<fpage>1291</fpage>–<lpage>1293</lpage>. <pub-id pub-id-type="doi">10.1097/WNR.0b013e328273bcb0</pub-id>
<pub-id pub-id-type="pmid">17632285</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritchie</surname><given-names>M. D.</given-names></name><name><surname>Hahn</surname><given-names>L. W.</given-names></name><name><surname>Roodi</surname><given-names>N.</given-names></name><name><surname>Bailey</surname><given-names>L. R.</given-names></name><name><surname>Dupont</surname><given-names>W. D.</given-names></name><name><surname>Parl</surname><given-names>F. F.</given-names></name><etal></etal></person-group> (<year>2001</year>). <article-title>Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer.</article-title>
<volume>69</volume>
<fpage>138</fpage>–<lpage>147</lpage>. <pub-id pub-id-type="doi">10.1086/321276</pub-id>
<pub-id pub-id-type="pmid">11404819</pub-id></mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanchez-Mora</surname><given-names>C.</given-names></name><name><surname>Ribases</surname><given-names>M.</given-names></name><name><surname>Ramos-Quiroga</surname><given-names>J. A.</given-names></name><name><surname>Casas</surname><given-names>M.</given-names></name><name><surname>Bosch</surname><given-names>R.</given-names></name><name><surname>Boreatti-Hummer</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Meta-analysis of brain-derived neurotrophic factor p.Val66Met in adult ADHD in four European populations.</article-title>
<volume>153B</volume>
<fpage>512</fpage>–<lpage>523</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.b.31008</pub-id>
<pub-id pub-id-type="pmid">19603419</pub-id></mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shalev</surname><given-names>I.</given-names></name><name><surname>Lerer</surname><given-names>E.</given-names></name><name><surname>Israel</surname><given-names>S.</given-names></name><name><surname>Uzefovsky</surname><given-names>F.</given-names></name><name><surname>Gritsenko</surname><given-names>I.</given-names></name><name><surname>Mankuta</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2009</year>). <article-title>BDNF Val66Met polymorphism is associated with HPA axis reactivity to psychological stress characterized by genotype and gender interactions.</article-title>
<volume>34</volume>
<fpage>382</fpage>–<lpage>388</lpage>. <pub-id pub-id-type="doi">10.1016/j.psyneuen.2008.09.017</pub-id>
<pub-id pub-id-type="pmid">18990498</pub-id></mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silhol</surname><given-names>M.</given-names></name><name><surname>Bonnichon</surname><given-names>V.</given-names></name><name><surname>Rage</surname><given-names>F.</given-names></name><name><surname>Tapia-Arancibia</surname><given-names>L.</given-names></name></person-group> (<year>2005</year>). <article-title>Age-related changes in brain-derived neurotrophic factor and tyrosine kinase receptor isoforms in the hippocampus and hypothalamus in male rats.</article-title>
<volume>132</volume>
<fpage>613</fpage>–<lpage>624</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2005.01.008</pub-id>
<pub-id pub-id-type="pmid">15837123</pub-id></mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sim</surname><given-names>M. S.</given-names></name><name><surname>Mohamed</surname><given-names>Z.</given-names></name><name><surname>Hatim</surname><given-names>A.</given-names></name><name><surname>Rajagopal</surname><given-names>V. L.</given-names></name><name><surname>Habil</surname><given-names>M. H.</given-names></name></person-group> (<year>2010</year>). <article-title>Association of brain-derived neurotrophic factor (Val66Met) genetic polymorphism with methamphetamine dependence in a Malaysian population.</article-title>
<volume>1357</volume>
<fpage>91</fpage>–<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2010.08.053</pub-id>
<pub-id pub-id-type="pmid">20736000</pub-id></mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sklar</surname><given-names>P.</given-names></name><name><surname>Gabriel</surname><given-names>S. B.</given-names></name><name><surname>Mcinnis</surname><given-names>M. G.</given-names></name><name><surname>Bennett</surname><given-names>P.</given-names></name><name><surname>Lim</surname><given-names>Y.</given-names></name><name><surname>Tsan</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2002</year>). <article-title>Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor.</article-title>
<volume>7</volume>
<fpage>579</fpage>–<lpage>593</lpage>. <pub-id pub-id-type="doi">10.1038/sj.mp.4001058</pub-id>
<pub-id pub-id-type="pmid">12140781</pub-id></mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soliman</surname><given-names>F.</given-names></name><name><surname>Glatt</surname><given-names>C. E.</given-names></name><name><surname>Bath</surname><given-names>K. G.</given-names></name><name><surname>Levita</surname><given-names>L.</given-names></name><name><surname>Jones</surname><given-names>R. M.</given-names></name><name><surname>Pattwell</surname><given-names>S. S.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>A genetic variant BDNF polymorphism alters extinction learning in both mouse and human.</article-title>
<volume>327</volume>
<fpage>863</fpage>–<lpage>866</lpage>. <pub-id pub-id-type="doi">10.1126/science.1181886</pub-id>
<pub-id pub-id-type="pmid">20075215</pub-id></mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spencer-Segal</surname><given-names>J. L.</given-names></name><name><surname>Waters</surname><given-names>E. M.</given-names></name><name><surname>Bath</surname><given-names>K. G.</given-names></name><name><surname>Chao</surname><given-names>M. V.</given-names></name><name><surname>Mcewen</surname><given-names>B. S.</given-names></name><name><surname>Milner</surname><given-names>T. A.</given-names></name></person-group> (<year>2011</year>). <article-title>Distribution of phosphorylated TrkB receptor in the mouse hippocampal formation depends on sex and estrous cycle stage.</article-title>
<volume>31</volume>
<fpage>6780</fpage>–<lpage>6790</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0910-11.2011</pub-id>
<pub-id pub-id-type="pmid">21543608</pub-id></mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szapacs</surname><given-names>M. E.</given-names></name><name><surname>Mathews</surname><given-names>T. A.</given-names></name><name><surname>Tessarollo</surname><given-names>L.</given-names></name><name><surname>Ernest Lyons</surname><given-names>W.</given-names></name><name><surname>Mamounas</surname><given-names>L. A.</given-names></name><name><surname>Andrews</surname><given-names>A. M.</given-names></name></person-group> (<year>2004</year>). <article-title>Exploring the relationship between serotonin and brain-derived neurotrophic factor: analysis of BDNF protein and extraneuronal 5-HT in mice with reduced serotonin transporter or BDNF expression.</article-title>
<volume>140</volume>
<fpage>81</fpage>–<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1016/j.jneumeth.2004.03.026</pub-id>
<pub-id pub-id-type="pmid">15589338</pub-id></mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terracciano</surname><given-names>A.</given-names></name><name><surname>Piras</surname><given-names>M. G.</given-names></name><name><surname>Lobina</surname><given-names>M.</given-names></name><name><surname>Mulas</surname><given-names>A.</given-names></name><name><surname>Meirelles</surname><given-names>O.</given-names></name><name><surname>Sutin</surname><given-names>A. R.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Genetics of serum BDNF: meta-analysis of the Val66Met and genome-wide association study.</article-title>
<volume>14</volume>
<fpage>583</fpage>–<lpage>589</lpage>. <pub-id pub-id-type="doi">10.3109/15622975.2011.616533</pub-id>
<pub-id pub-id-type="pmid">22047184</pub-id></mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terracciano</surname><given-names>A.</given-names></name><name><surname>Tanaka</surname><given-names>T.</given-names></name><name><surname>Sutin</surname><given-names>A. R.</given-names></name><name><surname>Deiana</surname><given-names>B.</given-names></name><name><surname>Balaci</surname><given-names>L.</given-names></name><name><surname>Sanna</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>BDNF Val66Met is associated with introversion and interacts with 5-HTTLPR to influence neuroticism.</article-title>
<volume>35</volume>
<fpage>1083</fpage>–<lpage>1089</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2009.213</pub-id>
<pub-id pub-id-type="pmid">20042999</pub-id></mixed-citation>
</ref>
<ref id="B125">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terrazzino</surname><given-names>S.</given-names></name><name><surname>Cargnin</surname><given-names>S.</given-names></name><name><surname>Viana</surname><given-names>M.</given-names></name><name><surname>Sances</surname><given-names>G.</given-names></name><name><surname>Tassorelli</surname><given-names>C.</given-names></name></person-group> (<year>2017</year>). <article-title>Brain-derived neurotrophic factor val66met gene polymorphism impacts on migraine susceptibility: a meta-analysis of case-control studies.</article-title>
<volume>8</volume>:<issue>159</issue>. <pub-id pub-id-type="doi">10.3389/fneur.2017.00159</pub-id>
<pub-id pub-id-type="pmid">28507530</pub-id></mixed-citation>
</ref>
<ref id="B126">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toran-Allerand</surname><given-names>C. D.</given-names></name><name><surname>Miranda</surname><given-names>R. C.</given-names></name><name><surname>Bentham</surname><given-names>W. D.</given-names></name><name><surname>Sohrabji</surname><given-names>F.</given-names></name><name><surname>Brown</surname><given-names>T. J.</given-names></name><name><surname>Hochberg</surname><given-names>R. B.</given-names></name><etal></etal></person-group> (<year>1992</year>). <article-title>Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain.</article-title>
<volume>89</volume>
<fpage>4668</fpage>–<lpage>4672</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.89.10.4668</pub-id>
<pub-id pub-id-type="pmid">1316615</pub-id></mixed-citation>
</ref>
<ref id="B127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>S. J.</given-names></name></person-group> (<year>2003a</year>). <article-title>Attention-deficit hyperactivity disorder and brain-derived neurotrophic factor: a speculative hypothesis.</article-title>
<volume>60</volume>
<fpage>849</fpage>–<lpage>851</lpage>. <pub-id pub-id-type="pmid">12699711</pub-id></mixed-citation>
</ref>
<ref id="B128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>S. J.</given-names></name></person-group> (<year>2003b</year>). <article-title>Brain-derived neurotrophic factor: a bridge between major depression and Alzheimer’s disease?</article-title>
<volume>61</volume>
<fpage>110</fpage>–<lpage>113</lpage>. <pub-id pub-id-type="pmid">12781652</pub-id></mixed-citation>
</ref>
<ref id="B129">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>S. J.</given-names></name></person-group> (<year>2004a</year>). <article-title>Down-regulation of the Trk-B signal pathway: the possible pathogenesis of major depression.</article-title>
<volume>62</volume>
<fpage>215</fpage>–<lpage>218</lpage>. <pub-id pub-id-type="pmid">14962629</pub-id></mixed-citation>
</ref>
<ref id="B130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>S. J.</given-names></name></person-group> (<year>2004b</year>). <article-title>Is mania caused by overactivity of central brain-derived neurotrophic factor?</article-title>
<volume>62</volume>
<fpage>19</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="pmid">14728999</pub-id></mixed-citation>
</ref>
<ref id="B131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>S. J.</given-names></name></person-group> (<year>2005</year>). <article-title>Is autism caused by early hyperactivity of brain-derived neurotrophic factor?</article-title>
<volume>65</volume>
<fpage>79</fpage>–<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1016/j.mehy.2005.01.034</pub-id>
<pub-id pub-id-type="pmid">15893122</pub-id></mixed-citation>
</ref>
<ref id="B132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>S. J.</given-names></name></person-group> (<year>2006</year>). <article-title>TrkB partial agonists: potential treatment strategy for epilepsy, mania, and autism.</article-title>
<volume>66</volume>
<fpage>173</fpage>–<lpage>175</lpage>. <pub-id pub-id-type="doi">10.1016/j.mehy.2005.05.033</pub-id>
<pub-id pub-id-type="pmid">16023301</pub-id></mixed-citation>
</ref>
<ref id="B133">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>S. J.</given-names></name></person-group> (<year>2007a</year>). <article-title>Increased central brain-derived neurotrophic factor activity could be a risk factor for substance abuse: implications for treatment.</article-title>
<volume>68</volume>
<fpage>410</fpage>–<lpage>414</lpage>. <pub-id pub-id-type="pmid">16824691</pub-id></mixed-citation>
</ref>
<ref id="B134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>S. J.</given-names></name></person-group> (<year>2007b</year>). <article-title>The P11, tPA/plasminogen system and brain-derived neurotrophic factor: implications for the pathogenesis of major depression and the therapeutic mechanism of antidepressants.</article-title>
<volume>68</volume>
<fpage>180</fpage>–<lpage>183</lpage>. <pub-id pub-id-type="pmid">16890384</pub-id></mixed-citation>
</ref>
<ref id="B135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>S. J.</given-names></name></person-group> (<year>2007c</year>). <article-title>TrkB partial agonists: potential treatment strategy for major depression.</article-title>
<volume>68</volume>
<fpage>674</fpage>–<lpage>676</lpage>. <pub-id pub-id-type="doi">10.1016/j.mehy.2006.06.019</pub-id>
<pub-id pub-id-type="pmid">16905274</pub-id></mixed-citation>
</ref>
<ref id="B136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>S. J.</given-names></name></person-group> (<year>2017a</year>). <article-title>Role of neurotrophic factors in attention deficit hyperactivity disorder.</article-title>
<volume>34</volume>
<fpage>35</fpage>–<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1016/j.cytogfr.2016.11.003</pub-id>
<pub-id pub-id-type="pmid">27919646</pub-id></mixed-citation>
</ref>
<ref id="B137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>S. J.</given-names></name></person-group> (<year>2017b</year>). <article-title>Role of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in psychological stress and depression.</article-title>
<volume>8</volume>
<fpage>113258</fpage>–<lpage>113268</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.19935</pub-id>
<pub-id pub-id-type="pmid">29348904</pub-id></mixed-citation>
</ref>
<ref id="B138">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>S. J.</given-names></name><name><surname>Cheng</surname><given-names>C. Y.</given-names></name><name><surname>Yu</surname><given-names>Y. W.</given-names></name><name><surname>Chen</surname><given-names>T. J.</given-names></name><name><surname>Hong</surname><given-names>C. J.</given-names></name></person-group> (<year>2003</year>). <article-title>Association study of a brain-derived neurotrophic-factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response.</article-title>
<volume>123B</volume>
<fpage>19</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.b.20026</pub-id>
<pub-id pub-id-type="pmid">14582140</pub-id></mixed-citation>
</ref>
<ref id="B139">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>S. J.</given-names></name><name><surname>Gau</surname><given-names>Y. T.</given-names></name><name><surname>Liu</surname><given-names>M. E.</given-names></name><name><surname>Hsieh</surname><given-names>C. H.</given-names></name><name><surname>Liou</surname><given-names>Y. J.</given-names></name><name><surname>Hong</surname><given-names>C. J.</given-names></name></person-group> (<year>2008a</year>). <article-title>Association study of brain-derived neurotrophic factor and apolipoprotein E polymorphisms and cognitive function in aged males without dementia.</article-title>
<volume>433</volume>
<fpage>158</fpage>–<lpage>162</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2007.12.057</pub-id>
<pub-id pub-id-type="pmid">18242855</pub-id></mixed-citation>
</ref>
<ref id="B140">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>S. J.</given-names></name><name><surname>Hong</surname><given-names>C. J.</given-names></name><name><surname>Liou</surname><given-names>Y. J.</given-names></name></person-group> (<year>2008b</year>). <article-title>Brain-derived neurotrophic factor and antidepressant action: another piece of evidence from pharmacogenetics.</article-title>
<volume>9</volume>
<fpage>1353</fpage>–<lpage>1358</lpage>. <pub-id pub-id-type="doi">10.2217/14622416.9.9.1353</pub-id>
<pub-id pub-id-type="pmid">18781861</pub-id></mixed-citation>
</ref>
<ref id="B141">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>S. J.</given-names></name><name><surname>Hong</surname><given-names>C. J.</given-names></name><name><surname>Liou</surname><given-names>Y. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Effects of BDNF polymorphisms on antidepressant action.</article-title>
<volume>7</volume>
<fpage>236</fpage>–<lpage>242</lpage>. <pub-id pub-id-type="doi">10.4306/pi.2010.7.4.236</pub-id>
<pub-id pub-id-type="pmid">21253406</pub-id></mixed-citation>
</ref>
<ref id="B142">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>S. J.</given-names></name><name><surname>Hong</surname><given-names>C. J.</given-names></name><name><surname>Liou</surname><given-names>Y. J.</given-names></name></person-group> (<year>2011</year>). <article-title>Recent molecular genetic studies and methodological issues in suicide research.</article-title>
<volume>35</volume>
<fpage>809</fpage>–<lpage>817</lpage>. <pub-id pub-id-type="doi">10.1016/j.pnpbp.2010.10.014</pub-id>
<pub-id pub-id-type="pmid">20977922</pub-id></mixed-citation>
</ref>
<ref id="B143">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>S. J.</given-names></name><name><surname>Hong</surname><given-names>C. J.</given-names></name><name><surname>Liu</surname><given-names>H. C.</given-names></name><name><surname>Liu</surname><given-names>T. Y.</given-names></name><name><surname>Hsu</surname><given-names>L. E.</given-names></name><name><surname>Lin</surname><given-names>C. H.</given-names></name></person-group> (<year>2004a</year>). <article-title>Association analysis of brain-derived neurotrophic factor Val66Met polymorphisms with Alzheimer’s disease and age of onset.</article-title>
<volume>49</volume>
<fpage>10</fpage>–<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1159/000075332</pub-id>
<pub-id pub-id-type="pmid">14730194</pub-id></mixed-citation>
</ref>
<ref id="B144">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>S. J.</given-names></name><name><surname>Hong</surname><given-names>C. J.</given-names></name><name><surname>Liu</surname><given-names>H. C.</given-names></name><name><surname>Liu</surname><given-names>T. Y.</given-names></name><name><surname>Liou</surname><given-names>Y. J.</given-names></name></person-group> (<year>2006</year>). <article-title>The brain-derived neurotrophic factor gene as a possible susceptibility candidate for Alzheimer’s disease in a Chinese population.</article-title>
<volume>21</volume>
<fpage>139</fpage>–<lpage>143</lpage>. <pub-id pub-id-type="doi">10.1159/000090673</pub-id>
<pub-id pub-id-type="pmid">16391475</pub-id></mixed-citation>
</ref>
<ref id="B145">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>S. J.</given-names></name><name><surname>Hong</surname><given-names>C. J.</given-names></name><name><surname>Yu</surname><given-names>Y. W.</given-names></name><name><surname>Chen</surname><given-names>T. J.</given-names></name></person-group> (<year>2004b</year>). <article-title>Association study of a brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and personality trait and intelligence in healthy young females.</article-title>
<volume>49</volume>
<fpage>13</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="pmid">14730195</pub-id></mixed-citation>
</ref>
<ref id="B146">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tzang</surname><given-names>R. F.</given-names></name><name><surname>Hsu</surname><given-names>C. D.</given-names></name><name><surname>Liou</surname><given-names>Y. J.</given-names></name><name><surname>Hong</surname><given-names>C. J.</given-names></name><name><surname>Tsai</surname><given-names>S. J.</given-names></name></person-group> (<year>2013</year>). <article-title>Family-based association of the brain-derived neurotrophic factor gene in attention-deficit hyperactivity disorder.</article-title>
<volume>23</volume>
<fpage>177</fpage>–<lpage>178</lpage>. <pub-id pub-id-type="doi">10.1097/YPG.0b013e328360c8a9</pub-id>
<pub-id pub-id-type="pmid">23528613</pub-id></mixed-citation>
</ref>
<ref id="B147">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uegaki</surname><given-names>K.</given-names></name><name><surname>Kumanogoh</surname><given-names>H.</given-names></name><name><surname>Mizui</surname><given-names>T.</given-names></name><name><surname>Hirokawa</surname><given-names>T.</given-names></name><name><surname>Ishikawa</surname><given-names>Y.</given-names></name><name><surname>Kojima</surname><given-names>M.</given-names></name></person-group> (<year>2017</year>). <article-title>BDNF binds its pro-peptide with high affinity and the common Val66Met polymorphism attenuates the interaction.</article-title>
<volume>18</volume>:<issue>E1042</issue>. <pub-id pub-id-type="doi">10.3390/ijms18051042</pub-id>
<pub-id pub-id-type="pmid">28498321</pub-id></mixed-citation>
</ref>
<ref id="B148">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ursini</surname><given-names>G.</given-names></name><name><surname>Cavalleri</surname><given-names>T.</given-names></name><name><surname>Fazio</surname><given-names>L.</given-names></name><name><surname>Angrisano</surname><given-names>T.</given-names></name><name><surname>Iacovelli</surname><given-names>L.</given-names></name><name><surname>Porcelli</surname><given-names>A.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>BDNF rs6265 methylation and genotype interact on risk for schizophrenia.</article-title>
<volume>11</volume>
<fpage>11</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1080/15592294.2015.1117736</pub-id>
<pub-id pub-id-type="pmid">26889735</pub-id></mixed-citation>
</ref>
<ref id="B149">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van den Buuse</surname><given-names>M.</given-names></name><name><surname>Lee</surname><given-names>J. J. W.</given-names></name><name><surname>Jaehne</surname><given-names>E. J.</given-names></name></person-group> (<year>2017</year>). <article-title>Interaction of brain-derived neurotrophic factor Val66Met genotype and history of stress in regulation of prepulse inhibition in mice.</article-title>
<pub-id pub-id-type="doi">10.1016/j.schres.2017.08.019</pub-id>
<comment>[Epub ahead of print]</comment>. <pub-id pub-id-type="pmid">28864281</pub-id></mixed-citation>
</ref>
<ref id="B150">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ventriglia</surname><given-names>M.</given-names></name><name><surname>Bocchio Chiavetto</surname><given-names>L.</given-names></name><name><surname>Benussi</surname><given-names>L.</given-names></name><name><surname>Binetti</surname><given-names>G.</given-names></name><name><surname>Zanetti</surname><given-names>O.</given-names></name><name><surname>Riva</surname><given-names>M. A.</given-names></name><etal></etal></person-group> (<year>2002</year>). <article-title>Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer’s disease.</article-title>
<volume>7</volume>
<fpage>136</fpage>–<lpage>137</lpage>. <pub-id pub-id-type="doi">10.1038/sj.mp.4000952</pub-id>
<pub-id pub-id-type="pmid">11840305</pub-id></mixed-citation>
</ref>
<ref id="B151">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verhagen</surname><given-names>M.</given-names></name><name><surname>Van Der Meij</surname><given-names>A.</given-names></name><name><surname>Van Deurzen</surname><given-names>P. A.</given-names></name><name><surname>Janzing</surname><given-names>J. G.</given-names></name><name><surname>Arias-Vasquez</surname><given-names>A.</given-names></name><name><surname>Buitelaar</surname><given-names>J. K.</given-names></name><etal></etal></person-group> (<year>2010</year>). <article-title>Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity.</article-title>
<volume>15</volume>
<fpage>260</fpage>–<lpage>271</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2008.109</pub-id>
<pub-id pub-id-type="pmid">18852698</pub-id></mixed-citation>
</ref>
<ref id="B152">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>F.</given-names></name><name><surname>Zhu</surname><given-names>W.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>Z.</given-names></name></person-group> (<year>2015</year>). <article-title>Meta-analysis of the association of brain-derived neurotrophic factor Val66Met polymorphism with obsessive-compulsive disorder.</article-title>
<volume>27</volume>
<fpage>327</fpage>–<lpage>335</lpage>. <pub-id pub-id-type="doi">10.1017/neu.2015.38</pub-id>
<pub-id pub-id-type="pmid">26503495</pub-id></mixed-citation>
</ref>
<ref id="B153">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>T.</given-names></name></person-group> (<year>2015</year>). <article-title>Does BDNF Val66Met polymorphism confer risk for posttraumatic stress disorder?</article-title>
<volume>71</volume>
<fpage>149</fpage>–<lpage>153</lpage>. <pub-id pub-id-type="doi">10.1159/000381352</pub-id>
<pub-id pub-id-type="pmid">25925851</pub-id></mixed-citation>
</ref>
<ref id="B154">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Gao</surname><given-names>K.</given-names></name><name><surname>Fang</surname><given-names>Y.</given-names></name></person-group> (<year>2014</year>). <article-title>Association between brain-derived neurotrophic factor genetic polymorphism Val66Met and susceptibility to bipolar disorder: a meta-analysis.</article-title>
<volume>14</volume>:<issue>366</issue>. <pub-id pub-id-type="doi">10.1186/s12888-014-0366-9</pub-id>
<pub-id pub-id-type="pmid">25539739</pub-id></mixed-citation>
</ref>
<ref id="B155">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warnault</surname><given-names>V.</given-names></name><name><surname>Darcq</surname><given-names>E.</given-names></name><name><surname>Morisot</surname><given-names>N.</given-names></name><name><surname>Phamluong</surname><given-names>K.</given-names></name><name><surname>Wilbrecht</surname><given-names>L.</given-names></name><name><surname>Massa</surname><given-names>S. M.</given-names></name><etal></etal></person-group> (<year>2016</year>). <article-title>The BDNF valine 68 to methionine polymorphism increases compulsive alcohol drinking in mice that is reversed by tropomyosin receptor kinase B activation.</article-title>
<volume>79</volume>
<fpage>463</fpage>–<lpage>473</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2015.06.007</pub-id>
<pub-id pub-id-type="pmid">26204799</pub-id></mixed-citation>
</ref>
<ref id="B156">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>S. M.</given-names></name><name><surname>Baller</surname><given-names>E. B.</given-names></name><name><surname>Kohn</surname><given-names>P. D.</given-names></name><name><surname>Kippenhan</surname><given-names>J. S.</given-names></name><name><surname>Kolachana</surname><given-names>B.</given-names></name><name><surname>Soldin</surname><given-names>S. J.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>Brain-derived neurotrophic factor Val66Met genotype and ovarian steroids interactively modulate working memory-related hippocampal function in women: a multimodal neuroimaging study.</article-title>
<volume>23</volume>
<fpage>1066</fpage>–<lpage>1075</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2017.72</pub-id>
<pub-id pub-id-type="pmid">28416813</pub-id></mixed-citation>
</ref>
<ref id="B157">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Y. C.</given-names></name><name><surname>Hill</surname><given-names>R. A.</given-names></name><name><surname>Gogos</surname><given-names>A.</given-names></name><name><surname>Van Den Buuse</surname><given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>Sex differences and the role of estrogen in animal models of schizophrenia: interaction with BDNF.</article-title>
<volume>239</volume>
<fpage>67</fpage>–<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2012.10.024</pub-id>
<pub-id pub-id-type="pmid">23085218</pub-id></mixed-citation>
</ref>
<ref id="B158">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>B.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Liu</surname><given-names>W.</given-names></name><name><surname>Jiang</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>R.</given-names></name><name><surname>Cui</surname><given-names>D.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>DNA methylation and tag SNPs of the BDNF gene in conversion of amnestic mild cognitive impairment into Alzheimer’s disease: a cross-sectional cohort study.</article-title>
<volume>58</volume>
<fpage>263</fpage>–<lpage>274</lpage>. <pub-id pub-id-type="doi">10.3233/JAD-170007</pub-id>
<pub-id pub-id-type="pmid">28387675</pub-id></mixed-citation>
</ref>
<ref id="B159">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>B.</given-names></name><name><surname>Gottschalk</surname><given-names>W.</given-names></name><name><surname>Chow</surname><given-names>A.</given-names></name><name><surname>Wilson</surname><given-names>R. I.</given-names></name><name><surname>Schnell</surname><given-names>E.</given-names></name><name><surname>Zang</surname><given-names>K.</given-names></name><etal></etal></person-group> (<year>2000</year>). <article-title>The role of brain-derived neurotrophic factor receptors in the mature hippocampus: modulation of long-term potentiation through a presynaptic mechanism involving TrkB.</article-title>
<volume>20</volume>
<fpage>6888</fpage>–<lpage>6897</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.20-18-06888.2000</pub-id>
<pub-id pub-id-type="pmid">10995833</pub-id></mixed-citation>
</ref>
<ref id="B160">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>M. Q.</given-names></name><name><surname>St Clair</surname><given-names>D.</given-names></name><name><surname>Feng</surname><given-names>G. Y.</given-names></name><name><surname>Lin</surname><given-names>Z. G.</given-names></name><name><surname>He</surname><given-names>G.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>BDNF gene is a genetic risk factor for schizophrenia and is related to the chlorpromazine-induced extrapyramidal syndrome in the Chinese population.</article-title>
<volume>18</volume>
<fpage>449</fpage>–<lpage>457</lpage>. <pub-id pub-id-type="doi">10.1097/FPC.0b013e3282f85e26</pub-id>
<pub-id pub-id-type="pmid">18408624</pub-id></mixed-citation>
</ref>
<ref id="B161">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>M. Q.</given-names></name><name><surname>St Clair</surname><given-names>D.</given-names></name><name><surname>Ott</surname><given-names>J.</given-names></name><name><surname>Feng</surname><given-names>G. Y.</given-names></name><name><surname>He</surname><given-names>L.</given-names></name></person-group> (<year>2007</year>). <article-title>Brain-derived neurotrophic factor gene C-270T and Val66Met functional polymorphisms and risk of schizophrenia: a moderate-scale population-based study and meta-analysis.</article-title>
<volume>91</volume>
<fpage>6</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1016/j.schres.2006.12.008</pub-id>
<pub-id pub-id-type="pmid">17289348</pub-id></mixed-citation>
</ref>
<ref id="B162">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>T.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Kuang</surname><given-names>W.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Brain-derived neurotrophic factor Val66Met polymorphism association with antidepressant efficacy: a systematic review and meta-analysis.</article-title>
<volume>6</volume>
<fpage>241</fpage>–<lpage>251</lpage>. <pub-id pub-id-type="doi">10.1111/appy.12148</pub-id>
<pub-id pub-id-type="pmid">25231750</pub-id></mixed-citation>
</ref>
<ref id="B163">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Harte-Hargrove</surname><given-names>L. C.</given-names></name><name><surname>Siao</surname><given-names>C. J.</given-names></name><name><surname>Marinic</surname><given-names>T.</given-names></name><name><surname>Clarke</surname><given-names>R.</given-names></name><name><surname>Ma</surname><given-names>Q.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>proBDNF negatively regulates neuronal remodeling, synaptic transmission, and synaptic plasticity in hippocampus.</article-title>
<volume>7</volume>
<fpage>796</fpage>–<lpage>806</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2014.03.040</pub-id>
<pub-id pub-id-type="pmid">24746813</pub-id></mixed-citation>
</ref>
<ref id="B164">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeh</surname><given-names>F. C.</given-names></name><name><surname>Kao</surname><given-names>C. F.</given-names></name><name><surname>Kuo</surname><given-names>P. H.</given-names></name></person-group> (<year>2015</year>). <article-title>Explore the features of brain-derived neurotrophic factor in mood disorders.</article-title>
<volume>10</volume>:<issue>e0128605</issue>. <pub-id pub-id-type="doi">10.1371/journal.pone.0128605</pub-id>
<pub-id pub-id-type="pmid">26091093</pub-id></mixed-citation>
</ref>
<ref id="B165">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>D. D.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>T.</given-names></name><name><surname>Lee</surname><given-names>F. S.</given-names></name><name><surname>Chen</surname><given-names>Z. Y.</given-names></name></person-group> (<year>2012</year>). <article-title>Variant brain-derived neurotrophic factor Val66Met polymorphism alters vulnerability to stress and response to antidepressants.</article-title>
<volume>32</volume>
<fpage>4092</fpage>–<lpage>4101</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5048-11.2012</pub-id>
<pub-id pub-id-type="pmid">22442074</pub-id></mixed-citation>
</ref>
<ref id="B166">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zai</surname><given-names>C. C.</given-names></name><name><surname>Manchia</surname><given-names>M.</given-names></name><name><surname>De Luca</surname><given-names>V.</given-names></name><name><surname>Tiwari</surname><given-names>A. K.</given-names></name><name><surname>Chowdhury</surname><given-names>N. I.</given-names></name><name><surname>Zai</surname><given-names>G. C.</given-names></name><etal></etal></person-group> (<year>2012</year>). <article-title>The brain-derived neurotrophic factor gene in suicidal behaviour: a meta-analysis.</article-title>
<volume>15</volume>
<fpage>1037</fpage>–<lpage>1042</lpage>. <pub-id pub-id-type="doi">10.1017/S1461145711001313</pub-id>
<pub-id pub-id-type="pmid">21875455</pub-id></mixed-citation>
</ref>
<ref id="B167">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Luo</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>Q.</given-names></name><name><surname>Xu</surname><given-names>R.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Huang</surname><given-names>Q.</given-names></name></person-group> (<year>2017</year>). <article-title>Peripheral brain-derived neurotrophic factor in attention-deficit/hyperactivity disorder: a comprehensive systematic review and meta-analysis.</article-title>
<volume>227</volume>
<fpage>298</fpage>–<lpage>304</lpage>. <pub-id pub-id-type="doi">10.1016/j.jad.2017.11.012</pub-id>
<pub-id pub-id-type="pmid">29132072</pub-id></mixed-citation>
</ref>
<ref id="B168">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>M.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Han</surname><given-names>D.</given-names></name><name><surname>Fang</surname><given-names>D.</given-names></name><name><surname>Qiu</surname><given-names>X.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>BDNF Val66Met polymorphism, life stress and depression: a meta-analysis of gene-environment interaction.</article-title>
<volume>227</volume>
<fpage>226</fpage>–<lpage>235</lpage>. <pub-id pub-id-type="doi">10.1016/j.jad.2017.10.024</pub-id>
<pub-id pub-id-type="pmid">29102837</pub-id></mixed-citation>
</ref>
<ref id="B169">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Q.</given-names></name><name><surname>Shen</surname><given-names>Y.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Si</surname><given-names>L.</given-names></name><name><surname>Jiang</surname><given-names>S.</given-names></name><name><surname>Qiu</surname><given-names>Y.</given-names></name></person-group> (<year>2017</year>). <article-title>Val66Met polymorphism in BDNF has no sexual and APOE epsilon4 status-based dimorphic effects on susceptibility to Alzheimer’s disease: evidence from an updated meta-analysis of case-control studies and high-throughput genotyping cohorts.</article-title>
<volume>33</volume>
<fpage>55</fpage>–<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1177/1533317517733037</pub-id>
<pub-id pub-id-type="pmid">28984138</pub-id></mixed-citation>
</ref>
<ref id="B170">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>X.</given-names></name><name><surname>Huang</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>K.</given-names></name><name><surname>Li</surname><given-names>D.</given-names></name><name><surname>Han</surname><given-names>C.</given-names></name><name><surname>Kan</surname><given-names>Q.</given-names></name></person-group> (<year>2015</year>). <article-title>The brain-derived neurotrophic factor Val66Met polymorphism is not associated with schizophrenia: an updated meta-analysis of 11,480 schizophrenia cases and 13,490 controls.</article-title>
<volume>225</volume>
<fpage>217</fpage>–<lpage>220</lpage>. <pub-id pub-id-type="doi">10.1016/j.psychres.2014.11.015</pub-id>
<pub-id pub-id-type="pmid">25468641</pub-id></mixed-citation>
</ref>
<ref id="B171">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zintzaras</surname><given-names>E.</given-names></name></person-group> (<year>2007</year>). <article-title>Brain-derived neurotrophic factor gene polymorphisms and schizophrenia: a meta-analysis.</article-title>
<volume>17</volume>
<fpage>69</fpage>–<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1097/YPG.0b013e32801119da</pub-id>
<pub-id pub-id-type="pmid">17413445</pub-id></mixed-citation>
</ref>
<ref id="B172">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zintzaras</surname><given-names>E.</given-names></name><name><surname>Hadjigeorgiou</surname><given-names>G. M.</given-names></name></person-group> (<year>2005</year>). <article-title>The role of G196A polymorphism in the brain-derived neurotrophic factor gene in the cause of Parkinson’s disease: a meta-analysis.</article-title>
<volume>50</volume>
<fpage>560</fpage>–<lpage>566</lpage>. <pub-id pub-id-type="doi">10.1007/s10038-005-0295-z</pub-id>
<pub-id pub-id-type="pmid">16172806</pub-id></mixed-citation>
</ref>
<ref id="B173">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zou</surname><given-names>Y. F.</given-names></name><name><surname>Ye</surname><given-names>D. Q.</given-names></name><name><surname>Feng</surname><given-names>X. L.</given-names></name><name><surname>Su</surname><given-names>H.</given-names></name><name><surname>Pan</surname><given-names>F. M.</given-names></name><name><surname>Liao</surname><given-names>F. F.</given-names></name></person-group> (<year>2010</year>). <article-title>Meta-analysis of BDNF Val66Met polymorphism association with treatment response in patients with major depressive disorder.</article-title>
<volume>20</volume>
<fpage>535</fpage>–<lpage>544</lpage>. <pub-id pub-id-type="doi">10.1016/j.euroneuro.2009.12.005</pub-id>
<pub-id pub-id-type="pmid">20167454</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>